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CHAPTER I 
STATEMENT OF THE PROBLEM 
Introduction 
Menopause is a natural biological event in the reproductive cycle of 
women usually experienced around their 50th birthday (MacPherson, 1981 ). 
It has been defined as the last menstruation in a woman's life (WHO, 1981 ). 
Menopause signals the end of a woman's reproductive ability and is 
accompanied by profound hormonal changes (Upton, 1982). 
Menopause has long been viewed as the onset of "the change", a lay 
term for menopause, for a midlife woman. In actuality, menopause may only 
signal the end of "the change" rather than the beginning, since many changes, 
physical, psychological, and physiological, occur years before the actual 
menopause, that is, during the perimenopausal period. 
Perimenopause is a process of gradual depletion of ovarian follicles 
leading to eventual cessation of ovarian function (Richardson & Nelson, 1994). 
Over the last few years, perimenopause has been increasingly recognized as not 
only a separate entity but also as more important than the actual menopausal 
or postmenopausal period. Many physical symptoms such as hot flashes and 
night sweats and/or psychosomatic symptoms such as depression, irritability, 
headache and sleep disturbance may occur more frequently at this time. 
It is estimated that there are currently more than 1 3 million 
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perimenopausal women in the United States. By the year 2000, there will be 
about 19 million women going through this perimenopausal transition 
(Bachmann, 1994a). Evidence exists that a third to one half of midlife women 
are affected by perimenopausal symptoms (McKinlay, Brambilla, & Posner, 
1992). With the increasing number of perimenopausal women in the United 
States, prevention and management of perimenopausal symptoms for midlife 
women becomes critical and must be emphasized. 
Traditional treatment for symptoms associated with perimenopause has 
been the administration of estrogens, either alone or in combination with 
progestin. However, hormone replacement therapy (HRT) is not without risk. 
Well-designed studies have demonstrated there is a significant linkage between 
estrogen and endometrial cancer. In addition, it has been reported that there 
was a 1 0% added risk of breast cancer among postmenopausal women who 
took estrogen for an average of 5. 7 years, a risk that was slightly increased 
with the addition of progestin (Wilbur, Dan, Hedricks, & Holm, 1990). 
Although the general consensus is that the benefits outweigh the risks, the 
concern remains. 
The evaluation of alternatives to estrogen therapy for symptom control 
during perimenopause is receiving increased attention. It is known that regular 
physical activity is beneficial in lessening a number of physical and mental 
s;ymptoms. Thus it is reasonable to ask whether physical activity will impact 
on symptoms associated with perimenopause as well. Further, the idea of a 
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protective effect of long term patterns of physical activity on perimenopausal 
symptoms is also plausible with precedence established for the beneficial 
effects of long term physical activity on coronary heart disease, hypertension, 
diabetes mellitus, and breast cancer (Pate et al., 1 995). 
Thus, physical activity may be one of the most promising alternatives to 
hormone therapy. However, to date the literature has been sparse concerning 
the relationships between symptom control at perimenopause and physical 
activity. Thus, the purpose of this study was to determine the relationships 
between physical activity and symptoms in perimenopausal women. 
Significance of the Study 
The information obtained from this study will contribute to the growing 
body of knowledge on determining the effectiveness of physical activity, an 
intervention that presents with minimal health risk, on symptoms associated 
with perimenopause. Nurses as well as physicians can become more 
knowledgeable regarding the effect of physical activity on perimenopausal 
symptoms. Nurses can play a significant role in encouraging, supporting, and 
teaching perimenopausal women to engage in regular physical activities. The 
development of regular physical activity habits in young girls and women of all 
ages could be an alternative and/or complementary solution for preventing and 
reducing perimenopausal symptoms. The introduction of physical activity 
regimens and the support of women engaged in regular physical activities could 
reduce human suffering from perimenopausal symptoms and enhance quality 
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of life of midlife women. 
CHAPTER II 
REVIEW OF THE LITERATURE 
Evolution of Definitions of Perimenopause 
Perimenopause has long been incorporated into the concept of 
menopause. In fact, perimenopause still is not listed in the Cumulated Index 
Medicus as a separate subject heading. Therefore, in order to understand the 
concept of perimenopause, the concept of menopause needs to be analyzed 
first. 
Literally, the term menopause is defined as a permanent cessation of 
menstruation resulting from loss of ovarian activity (WHO, 1981). It is a single 
point in time, the last menstruation. For the sake of accuracy, the diagnosis 
of menopause is made retrospectively after complete cessation of menses for 
a period of one year. 
Menopause can be natural, premature or artificial. Natural menopause 
is the spontaneous cessation of menses after the age of 40 years usually 
occurring around the age of 50 years (MacPherson, 1981). Spontaneous 
cessation of menses before the age of 40 years is called premature menopause 
or premature ovarian failure. For the premature menopausal women, the 
perimenopausal symptoms can occur as early as a few years after menarche 
(Vada & George, 1986). The etiology for premature ovarian failure is not 
5 
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known. Surgical or artificial menopause is defined as cessation of menstruation 
due to surgical removal of the uterus, ovaries, or both, with or without the use 
of hormone replacement therapy. 
A review of literature on menopause indicated that confusion exists 
regarding the definition of menopause. Menopause has been used in several 
ways: 1) as the end-point of reproductive life, that is, the last menstruation 
(WHO, 1981 ); 2) as a period of time before and after menopause (Hunter, 
1992); 3) as a period of time after menopause (MacPherson, 1981 ); and 4) as 
a time frame which includes the entire menopausal process of pre-, peri-, and 
postmenopausal period (Budoff & Sommers, 1979). Using different definitions 
of menopause results in a lack of conceptual clarity and methodological issues 
such as the inability to compare research findings across studies but also fails 
to recognize the distinctions between the different stages of the menopausal 
experience. 
Several terms have been used synonymously with menopause. One of 
these terms is the "change of life" which is no longer accepted by modern 
women. Another term used by researchers is climacteric which is defined as 
a transition from reproductive to nonreproductive life (Uphold & Sussman, 
1981 ). However, the latter concept has been used in an ambiguous manner and 
most researchers have found the term climacteric too vague to be useful. For 
example, the term climacteric refers to a time span of 5 to 25 years and its 
onset and duration is uncertain. Some researchers define it as extending well 
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into the postmenopausal years (Harper, 1990). 
Definitional issues related to menopause were addressed at the First 
International Congress on Menopause. In that meeting, menopause was 
defined as "the final menstrual period and occurs during the climacteric" (Utian, 
1980, p.3). It would seem that using the cessation of menses as a criterion to 
define menopause might have the advantage of providing a relatively objective, 
reliably determined and clearly marked distinction between the pre- and post-
menopausal women (Kaufert, 1986). However, this definition gives the faulty 
impression that there is an abrupt change in ovarian function (i.e. ovarian 
function is normal one day and ceases functioning the next day). Furthermore, 
including all premenopausal women in one category fails to discriminate 
between women who are menstruating regularly and those who have menstrual 
cycles that become increasingly irregular as they approach menopause. Thus, 
a new concept was needed to represent women who are approaching 
menopause. 
In 1967, Treloar, Boynton, Behn, and Brown introduced the concept of 
perimenopause. They indicated that the critical marker of perimenopause was 
menstrual irregularity, defined as genital bleeding changing to either longer or 
shorter than its usual flow intervals. 
Based on these ideas, the three-stage definition of menopausal status 
was introduced by Jaszmann, van Lith, and Zaat ( 1969). Their definition of 
menopause status was as follows: 
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"Premenopause: Women who had normal menses for the past year; 
Menopausal: Women reporting a menstrual pattern different from the 
former pattern, i.e., those who had more or fewer menstrual flows than 
previously over the past year; Postmenopause: Women who did not 
menstruate in the past year" (p. 269). 
In this article, the period of change in menstrual pattern was recognized as a 
distinct stage, although the stage was termed menopausal rather than 
perimenopause. This study marked the emergence of the concept of 
perimenopause. 
The definitions of perimenopause along with the definitions of 
menopausal status were modified by the World Health Organization's (WHO) 
technical report ( 1981), "Research on Menopause". The following definitions 
were given: 
"Menopause: the permanent cessation of menstruation resulting from 
loss of ovarian, follicular activity; Perimenopause (or climacteric): the 
period immediately prior to menopause when endocrinological, biological, 
and clinical features of approaching menopause commence, continuing 
for at least the first year after the menopause; Postmenopause: a period 
dating from menopause, although it cannot be determined until after 12 
months of spontaneous amenorrhea; Premenopause: the whole of the 
reproductive period prior to menopause" (p. 8). 
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Although WHO' s ( 1 981 ) definition of perimenopause was clear, its 
definition of premenopause was still ambiguous. The premenopausal and 
perimenopausal phases were not mutually exclusive. The definition of 
premenopause still included women who had entered the perimenopausal 
phase. Many researchers still found the definition too confusing to be useful. 
The three-stage definition of menopause status was further developed 
and modified (Kaufert et al., 1986) based on the previous works of Treloar et 
al. ( 1967) and Jaszmann et al. ( 1969) and the assumption of hormonal change. 
Women who reported no change in menstrual flow or frequency during the last 
1 2 months were defined as pre-menopausal. The underlying assumption is that 
menstrual pattern stability reflects hormonal stability. Women who reported no 
menses for twelve consecutive months or longer were defined as 
postmenopausal. The assumption is that after 1 2 months of amenorrhea, it is 
certain that ovulation has ceased and that hormonal levels within the ovary 
have stabilized at the postmenopausal level. Women who reported changes in 
menstrual flow or frequency during the last 1 2 months are categorized as 
perimenopausal. The basic assumption underlying perimenopause is that 
changes in menstrual pattern signify that menopause is inevitable (Kaufert et 
al., 1986). Therefore, perimenopause is defined as changes in menstrual flow 
or frequency or no menses for three to eleven months. 
The standard three-stage definition of menopausal status given by 
Kaufert et al., 1986 is useful because it recognizes the differences in 
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experience between pre-, peri- and postmenopausal women. In addition, 
researchers could use the same criterion to define status, and comparisons 
could be made between different study populations. 
Based on the three-stage definitions of menopausal status, 
perimenopause is generally a period of a few years before and one year after 
the menopause. It starts when the active ovary begins to fail and ends with the 
final lapse of the ovary into inactivity. During this period maximal reproductive 
hormone fluctuation occurs prior to the final menses (Kaufert, 1986). It is 
characterized endocrinologically by evidence of decreasing ovarian activity, 
biologically by decreasing fertility, and clinically by alteration in menstrual cycle 
intervals and maybe by a variety of symptoms (Upton, 1982). However, the 
criteria used to define perimenopause in clinical research generally include only 
changes in menstrual flow and/or regularity indicated by unusually long or short 
menstrual cycles, diminished menstrual flow, or intermittent menstrual cycles 
that terminate in menopause (Feldman, Voda, & Gronseth, 1985). The 
biological and endocrinological parameters are often not included because 1) 
measuring the hormone levels requires drawing blood and ordering lab tests 
which are inconvenient and costly and 2) it is inappropriate to determine a 
woman's fertility only for the purpose of menopausal research. 
In the perimenopausal literature, however, not all authors have used the 
standard three-stage definitions of perimenopause as described above. Some 
investigators loosely and inaccurately defined perimenopause as a period of 
11 
time around menopause (Cutick, 1984). Perimenopause has been used to refer 
to different age groups. For example, it was used to describe women 35 to 50 
years of age (Feldman, Voda, & Gronseth, 1985) or 25 to 74 years of age 
(VanHall, Vardel, & Velden, 1994). These studies used subjects with an age 
range of 1 5 years or more and considered these women as perimenopausal. 
Apparently women who were clearly "premenopausal and postmenopausal" 
were included in the perimenopausal category. 
Several other definitions of perimenopause have been used. First, 
perimenopause has been defined as an indefinite period of time that begins with 
the onset of the first hot flash and terminates when hot flashes disappear 
(Voda, 1984). This definition implies that perimenopause is not experienced 
by women who do not have hot flashes; women who do have hot flashes may 
experience them many years before menopause as well as many years after 
menopause. Although this definition provides an objective indicator of the 
onset and duration of perimenopause, it has little empirical value in terms of 
categorizing women, since not every woman has hot flashes during the 
menopausal process and not every woman who has hot flashes is 
perimenopausal. 
Finally, perimenopause has also been defined as a period which includes 
all three stages of menopause (Harper, 1990), thus the duration of 
perimenopause would be about 25 years (women aged 35-60). Obviously, this 
definition, including all menopausal women in the same group, fails to 
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demonstrate the difference in menopause experienced between the different 
stages of menopausal women. 
In summary, for the purpose of this study, perimenopause is defined as 
a few years before the actual menopause is diagnosed. It is primarily 
operationalized as the changes in menstrual pattern which includes menstrual 
cycle and/or flow irregularity and/or no menstruation for more than three and 
less than 12 months (Figure 1) in the past year. Since women who have a 
premature or surgical menopause have an atypical perimenopause experience, 
this study only focuses on natural perimenopause. 
Hormonal Aspects of Perimenopause 
Several studies (Hee, MacNaughton, Bangah, & Burger, 1993; Longcope, 
Franz, Morello, Baker, & Johnston, 1986; Richardson, Senikas, & Nelson, 
1987; Shideler, DeVane, Kalra, Benirchke, & Lasley, 1989; Trevoux, Brux, 
Castanier, Nahoul, Soule, & Scholler, 1986) have been conducted to describe 
the endocrine characteristics of menstrual cycles in perimenopausal women. 
Information was obtained from both cross-sectional and longitudinal data. 
Hormonal profiles of perimenopausal women are characterized by a great 
deal of variability and lack of predictability. According to Richardson and 
Nelson ( 1994), the human ovary steadily loses follicles from mid-fetal life. The 
number of follicles remaining in the mature ovary is the major determinant of 
the timing of both perimenopause and menopause. In a study of follicle number 
in ovaries in 17 healthy women aged 45 to 55 years, Richardson, Senikas, & 
Figure 1. The perimenopausal period 
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Nelson ( 1 987) found that the mean number of primordial follicles in the ovaries 
of women who were still menstruating regularly was ten-fold greater than in the 
ovaries of perimenopausal women of the same age. Follicles were fewer or 
absent from the ovaries of the postmenopausal women. They concluded that 
the size of the follicular reserve was the major determinant of both the 
transition from regular menses to the perimenopause as well as to the 
menopause itself (see Appendix A). 
With the decreased level of ovarian follicles in perimenopause, the 
secretion of estrogen is greatly diminished (Hee et al., 1993; Longcope et al., 
1986; Shideler et al., 1989; and Trevoux et al., 1986) (Table 1). 
Perimenopausal women have low levels of estrogen and progesterone that are 
midway between the normal reproductive range and the postmenopausal range 
(Hee et al., 1993). Estradiol remains the major form of estrogen during 
perimenopause. There is a great deal of day to day fluctuation in this hormone 
level. During the postmenopausal period, the major source of estrogen comes 
from the peripheral conversion of estrone and testosterone. Compared to pre-
and perimenopausal women, postmenopausal estrone levels are higher than 
estradiol levels (Greendale & Judd, 1993). 
Further, with decreased ovarian follicles, the follicle stimulating hormone 
(FSH) level becomes elevated as a compensatory mechanism in the 
perimenopausal period and remains elevated within the range defined as 
postmenopausal (Longcope et al., 1986). Luteal hormone (LH) level can be 
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elevated or remain in the normal range (Cook, 1993). 
The perimenopausal cycle can be ovulatory or anovulatory. The 
ovulatory cycle is characterized by a midcycle estrogen surge and subsequent 
luteal phase progesterone secretion that is lower than that found in the normal 
reproductive cycle, while the anovulatory cycle is characterized by a rise and 
fall in estrogen levels and no progesterone secretion (Upton, 1982). 
Clinically, perimenopausal women usually have either a shorter or longer 
menstrual cycle compared to premenopausal women. Short cycles are 
accompanied by shorter follicular phases (6-10 days in length) and a normal 
duration of luteal phase. The longer menstrual cycles are usually anovulatory 
and last 40 to 60 days. Furthermore, the menstrual cycles in perimenopausal 
women are irregular and unpredictable and can have a duration varying from 20 
to more than 60 days (Shermen, West, & Korenman, 1976). 
Methodological issues, however, have to be considered when interpreting 
data. Gonadotrophins are secreted episodically, yet some studies obtained 
individual blood samples at isolated time points (Longcope et al., 1986). These 
samples could have been obtained anywhere during or after a secretory 
episode. Therefore, bias due to timing or frequency of sampling might have 
occurred. Additionally, some studies used small sample sizes. For example, 
Shideler et al. ( 1 989) in their study used only two perimenopausal subjects; 
Hee et al. ( 1993) used three; and Richardson et al. ( 1987) used seven. 
Therefore, generalization of findings from these studies is difficult. 
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In summary, measuring the hormonal level may be a more objective way 
of defining menopausal status, but the cost and time frame for a doctoral study 
prohibited this approach for this study. In addition, menstrual cycle change 
during perimenopause closely reflects the hormonal change. Therefore, again, 
changes in menstrual patterns were used to define perimenopause in this study. 
Clinical Aspects of Perimenopause 
Age and Duration of Perimenopause 
The onset and the duration of perimenopause have not been widely 
studied. Only three studies were found which dealt with the age at onset and 
the duration of the perimenopause (see Appendix 8). In a survey of 6877 
women aged 38 to 58 years, Magursky, Mesko, and Sokolik ( 1975) found that 
the age at onset of the perimenopause was approximately 47.5 years. In this 
study, the term climacteric was used to mean perimenopause. These 
investigators noted that onsets of perimenopause and menopause were related 
to menstrual disturbance and occupation. Women with more menstrual 
disturbances had their menopause about one year earlier than other women. 
Women who were manual workers and those in occupations other than 
housewives and agricultural workers had their menopause and onset of 
perimenopause at least a year earlier. Age at menarche and parity was not 
associated with the age at the onset of perimenopause. 
Treloar ( 1 981), in a study of 291 women who were followed from the 
time of menarche to natural menopause, found that the median age for the 
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onset of perimenopause was 45.5 years, with a range of 34 to 55 years. The 
duration of perimenopause was 4.8 years (median value) with a range of one 
to 10 years. He also found a long perimenopause usually began with a slow 
increase in cyclic variations which were linked to duration of perimenopause. 
More than a decade later, McKinlay, Brambilla and Posner (1992) 
conducted a large and comprehensive prospective cohort study of 2500 mid-
aged women. Their results were strikingly similar to Magursky and colleagues' 
study in 1975. McKinlay et al. found that the onset of perimenopause was 
4 7. 5 years and the duration was about 4 years. They noted that there were 
several factors such as smoking that affected the onset and duration of 
perimenopause. Smokers tended to have not only an earlier, but also a shorter 
perimenopause. 
The discrepancies in age of inception of perimenopause noted in the 
above studies may be explained by the differing samples. Studies conducted 
by Magursky et al. ( 1975) and McKinlay et al. ( 1992) used women with more 
limited age ranges than Treloar's study (1981 ). Therefore, women with early 
perimenopause and menopause may not be represented in their samples. 
Conversely, Treloar' s ( 1981) study may have included women with premature 
menopause. 
In summary, age is an important factor in the onset of perimenopause. 
Most women will begin their perimenopause at about age 45 to 4 7 years. 
However, a few women may experience perimenopause as early as their late 
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30s and as late as their middle 50s. Perimenopause lasts one to ten years with 
an average of four years. In this study, women who have changes in their 
menstrual pattern and are aged 40 years and above are evaluated to exclude 
women who might experience premature menopause. 
Symptoms of Perimenopause 
A number of studies have reported on the incidence of symptoms 
reported by perimenopausal women (Seltzer, Benjamin & Doutsch, 1990; 
McKinlay et al., 1992; Holte, 1992; Dennerstein et al., 1993). A comparison 
of the findings of these studies is, however, limited by methodological issues. 
For example, some studies recruited women attending clinics as subjects 
(Seltzer et al., 1990) and others used nonclinical population samples (McKinlay 
et al., 1992). In addition, some studies failed to distinguish between 
perimenopausal and postmenopausal or between premenopausal and 
perimenopausal phases. 
Menstrual changes 
The first sign of perimenopause is a change in menstrual bleeding. The 
literature has consistently reported menstrual irregularity with either scanty or 
profuse bleeding during perimenopause (Bachmann, 1994b). It is believed that 
menstrual irregularity reflects marked fluctuations in levels of estrogen and 
progesterone or outright deficiency. Clinical studies of menopausal women 
have shown that approximately 90% of women will experience menstrual 
irregularity during perimenopausal years; only 10 to 12% of premenopausal 
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women will have sudden amenorrhea (McKinlay et al., 1992; Seltzer et al., 
1 990; Treloar et al., 1967). For example, a classic extensive longitudinal study 
of menstrual intervals throughout life by Treloar et al. ( 1967) found that 
beginning seven years before menopause, the incidence of short and long 
cycles dramatically increased and reached its peak about 4 years before 
menopause. During this time, the mean variability of menstrual intervals in 
individual women also increased. Further, Seltzer et al. ( 1 990), in a chart 
review study of 500 perimenopausal patients reporting alterations in menstrual 
flow, found 86. 7 % of perimenopausal women with irregular menstrual 
bleeding have oligomenorrhea, or abnormal menstrual periods (intervals of 36 
to 90 days between periods) or hypomenorrhea (regular menses but decreased 
in amount); and 13.3% report menorrhagia, metrorraghia, and hypermenorrhea 
(see Table 1 ). However, caution has to be taken when interpreting this study 
because the study was retrospective and data were obtained by chart reviews 
of the clinical population. Thus, the incidence of menstrual problems may not 
be representative of the general population. 
Abnormal bleeding can be disturbing, especially if it's heavy and 
unpredictable. McKinlay and colleagues ( 1992) indicated that irregular 
menstrual bleeding during perimenopause appears to be more worrisome to 
women than hot flashes, particularly if this irregular menstrual bleeding persists 
beyond a year or two. While clinical papers emphasize menstrual problems 
during perimenopause (Bachmann, 1994a), such menstrual problems did not 
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stand out as a significant symptom in research studies. This may reflect 
researchers' bias in the measurement of symptoms during perimenopause. 
Either menstrual problems were not included in the measurement tool or were 
not analyzed as separate symptoms. Consequently, menstrual problems may 
not have been evident because they were grouped into the "other" categories. 
In this study, prevalence of menstrual changes measured by several items and 
the effect of long term physical activity on menstrual changes were evaluated. 
Table 1. 
Examples of menstrual irregularity during perimenopause 
Type of menstrual irregularity Definition 
Oligomenorrhea Scanty or infrequent menstrual flow 
Abnormal menstrual periods Irregular menstrual flow 
Hypomenorrhea Deficient amount of menstrual flow 
but periods are regular 
Menorrhagia Excessive bleeding at the time of a 
menstrual period, either in number of 
days or amount of blood or both 
Metrorraghia Bleeding from the uterus, esp. at any 
time other than during the menstrual 
period 
Vasomotor symptoms 
Although some years ago researchers believed that most menopausal 
symptoms started with the onset of menopause, current data suggest that 
vasomotor symptoms, psychosomatic symptoms and sexual problems may 
begin during the pre- and perimenopausal period. All studies reviewed, both 
cross-sectional and longitudinal, demonstrated a marked and significant 
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increase in vasomotor symptoms such as hot flashes and night sweats, during 
the perimenopausal period (Avis, Kaufert, Lock, McKinlay, & Vass, 1993; 
Ballinger, 1985; Dennerstein et al., 1993; Hunter, 1992; McKinlay et al., 1992) 
(see Appendix C); and all studies reviewed found a significant relationship 
between vasomotor symptoms and menopausal status (see Appendix D). 
Hot flashes have been described by women as strong sensations of 
warmth, skin irritation, and perspiration that travel from the trunk toward the 
head before spontaneously disappearing. Hot flashes may be spontaneous, 
uncomfortable, and unpredictable, and may occur any time of the day or night. 
Episodes may last from seconds to minutes and occur frequently with varying 
intensity (Feldman et al., 1985). Hot flashes are often temporary but may last 
one to five years. 
Estimates of prevalence of hot flashes in population studies ranged from 
31-50% depending on the geographic region (Avis et al., 1993; Hunter, 1992; 
Jaszmann et al., 1969; McKinlay et al., 1992). Discrepancies in prevalence of 
vasomotor symptoms reported in epidemiologic surveys probably reflect 
inconsistencies in research methodologies. For example, the different methods 
of data collection may have influenced responses. A mailed questionnaire was 
used as a mode of data collection in Avis and colleagues' study (1993), while 
a combination of telephone interview and postal questionnaire methods were 
used in McKinlay and colleagues' study (1992). Interview as a method of data 
collection may increase the accuracy of data, yet interviewer-bias may also be 
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manifested. 
Vasomotor symptoms are not unique to perimenopause; they occur 
throughout the reproductive years. However, the majority of studies (see 
Appendix C) reviewed found occurrence of vasomotor symptoms to peak during 
perimenopause. For example, MacKinlay and colleagues ( 1992) conducted 
probably the largest and most comprehensive prospective cohort study of 
middle-aged women, the Massachusetts Women's Health Study (MWHS). 
They studied 1178 women between the ages of 45 to 55 years. This 
prospective study consisted of six telephone contacts at nine-month intervals. 
They reported that hot flashes were experienced in only 10% of premenopausal 
women. This incidence rate increased slowly before the transition to 
perimenopause, then increased rapidly during perimenopause to a peak of 
about 50% during the last year of perimenopause (the year just after the 
cessation of menses). Then the rate began to decrease. At four years after the 
last menstrual period, the rate of hot flashes had declined to 20%. 
Vasomotor symptoms have strong associations with other symptoms 
presumably associated with perimenopause such as cold sweats, insomnia, 
fatigue, nervousness, and depression (Utian, 1980). The majority of women 
who reported experiencing hot flashes also reported cold sweats. Insomnia 
was more likely to be reported by women who experienced hot flashes. This 
phenomenon may be due to sleep disturbance from frequent episodes of hot 
flashes and cold sweats during the night (Hunter, 1992; MacKinlay et al., 
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1992). 
Attempts have been made to identify the factors that might predi.ct 
women experiencing vasomotor symptoms. Length of perimenopause was 
found to be related to the occurrence of vasomotor symptoms (McKinlay et al., 
1992). Women with shorter or no perimenopause were less likely to have hot 
flashes than women with a longer perimenopause. The differences in 
percentage of incidence of vasomotor symptoms between women with average 
length of perimenopause and those with short or no perimenopause phase was 
12%. Women with a longer perimenopause were also likely to have menstrual 
problems (McKinlay et al., 1992). 
A history of premenstrual tension and/or having vasomotor symptoms 
when menstruating regularly before perimenopause has been correlated with 
vasomotor symptoms during perimenopause (Hunter, 1 990). The author gave 
three explanations. First, there may be some type of hormonal pattern 
predisposing women to both kinds of symptoms. Second, vasomotor 
symptoms may be an illness behavior. Some people complain more about a 
whole host of symptoms because they are more preoccupied by bodily 
changes. Finally, women with a history of menstrual problems may develop 
learned reactions to reproductive changes. 
In summary, consensus has been reached that there is a significant 
relationship between vasomotor symptoms and menopausal status. In this 
study, occurrence and distress associated with vasomotor symptoms and 
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impact of long term physical activity on vasomotor symptoms were examined. 
Psychosomatic symptoms 
Historically a variety of psychosomatic complaints, such as clinical 
depression, anxiety or irritability, depressed mood, feeling blue, fatigue, 
palpitations, headache, and insomnia have been attributed to perimenopause, 
since these symptoms seem slightly increased during this period (Holte, 1992). 
It has been reported that perimenopausal women had significantly higher levels 
of psychologic distress and more psychosomatic symptoms than pre- and 
postmenopausal women (Dennerstein et al., 1993; Stewart, Boydell, Derzko, 
and Marshall, 1992). For example, Stewart, Boydell, Derzko, and Marshall 
( 1 992), in a study of psychological distress in peri- and postmenopausal women 
(peri-, n = 113 and postmenopause, n = 146) attending a menopause clinic, 
found that perimenopausal women had significantly higher levels of psychologic 
distress. Furthermore, Dennerstein et al. ( 1993), in a study of 2000 women 
aged 45-55 years, found that premenopausal women were the least 
symptomatic and perimenopausal women the most symptomatic. Vasomotor 
symptoms and general psychosomatic symptoms were more frequent in the 
perimenopause. 
Psychosomatic symptoms during the entire menopausal period include 
depression, fatigue, irritability, sleep disturbance, and mood change. In general, 
the incidence of psychosomatic symptoms is higher in perimenopausal than in 
premenopausal women, yet the degree of difference in incidence of 
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psychosomatic symptoms is much lower than that of vasomotor symptoms. 
Furthermore, whether the increase in psychosomatic symptoms during midlife 
is associated with perimenopause and menopause remains unanswered. 
In the last decade, a number of cross-sectional studies of midlife women 
have been conducted to study the relationship between psychosomatic 
symptoms and menopausal status. The few conflicting results such as the 
relationship between menopausal status and depression may be explained by 
methodological problems, for example, the confounding effects of age, and the 
use of different lists of menopausal symptoms and different definitions of 
psychosomatic symptoms. In addition, strongly held beliefs and expectations 
regarding menopause are likely to influence women's responses to 
questionnaires if they are aware that menopause is being investigated. 
In the past five years, several prospective studies have examined the 
relationship between psychosomatic symptoms and menopausal status (Holte, 
1992; Hunter, 1990; McKinlay et al., 1992). Strengths of these studies 
include the use of the standard three-stage definition of menopausal status, and 
following women for several years so that the data represent the entire 
perimenopausal period. 
Although the majority of the longitudinal studies did not find a significant 
relationship between psychosomatic symptoms, for example, depression, and 
menopausal status, one investigator (Hunter et al., 1986; Hunter, 1992) found 
that depression was significantly related to menopause. The conflicting results 
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may well be explained by the different definitions and measurements of 
depression used in various studies. While Hunter ( 1 992) viewed depression as 
depressed mood and feeling blue, Kaufert et al. ( 1 988) focused on measuring 
depressive symptoms more than mood change. Therefore, it seems likely that 
the use of different operational definitions of depression contributes to 
equivocal findings. There seems to be a trend that depressed mood is related 
to perimenopause, while depressive symptoms and clinical depression are not 
(Ballinger, 1990). In the current study, depressed mood and psychosomatic 
symptoms such as headache, nervousness, and their relationship to regular 
physical activity were evaluated. 
Disturbances of sexuality 
Although the disturbance of sexuality may be more of a problem for 
postmenopausal women, it may also occur in perimenopausal women. 
Depending on the demographics of the population studied, the definition used 
for sexual disturbance and on the particular sexual behavior reported, studies 
evaluating sexual function in midlife women found that the incidence of sexual 
disturbances ranged from 5 to 85% (Davidsen, 1985; Hallstrom, 1973; Hunter, 
1992; Koster & Davidsen, 1993). The determinants of sexual behavior are 
thought to be complex and interrelated. According to Greendale and Judd 
( 1993), sexual function is regulated by three general components: "the 
individual motivation (also called desire or libido), endocrine competence, and 
social-cultural beliefs" (p. 429). 
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Women attending clinics with perimenopausal complaints commonly 
report vaginal dryness and associated dyspareunia (Davidsen, 1985; Hunter, 
1 992). It is generally agreed that vaginal dryness is associated with low 
estrogen levels during perimenopause (Hunter, 1993). Vaginal dryness may 
affect sexual functioning and possibly lead to a decline in sexual enjoyment and 
interest. According to Bachmann ( 1994), during perimenopause, women often 
report a decrease in sexual desire and a diminished amount of vaginal 
lubrication with sexual arousal and coitus. Inadequate vaginal lubrication may 
lead to insertional dyspareunia. Similarly, Koster & Davidsen ( 1993) found that 
30% of women experienced a decrease in sexual desire. Bachmann ( 1994) 
reported that there was a gradual decline in sexual arousal and a progressive 
decrease in coital frequency starting early in perimenopause. 
A few available studies have found that decrease in sexual desire was 
not related to menopausal status (Hunter, 1992; Koster & Davidsen, 1993). In 
contrast, the change in sexual desire was highly correlated to previous and 
· present subjective health status, former sexual activity, partner availability and 
social status, and women's subjective assessment of being perimenopausal. 
In the current study, the sexuality of perimenopausal women was examined . 
./ In summary, many questions remain unanswered regarding the 
perimenopausal experience. It is significant to note that not all perimenopausal 
women experience symptoms around menopause. Therefore, it is important to 
identify factors that influence the occurrence and intensity of perimenopausal 
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symptoms. In the current study, the perimenopausal experience of long term 
physically active women was described. In addition, whether regular physical 
activity contributes to the improvement of perimenopausal experience was 
evaluated. 
Concept of Physical Activity 
Physical activity as a health related behavior has been widely used and 
studied. Viewed as a behavior, physical activity has been defined as "any 
bodily movement produced by skeletal muscles that results in energy 
expenditure" (Caspersen, Powell, & Christenson, 1985). Exercise is a subtype 
of physical activity. It is planned, structured and repetitive. In the literature, 
physical activity and exercise has been used interchangeably. Regular 
moderate physical activity is an activity performed at least five times a week, 
at an intensity of 3-6 METs (work metabolic rate/resting metabolic rate-the 
equivalent of brisk walking at 3-4 mph for most healthy adults). Recent 
research suggested that it is a misperception of many people that to reap health 
benefits they must engage in vigorous, continuous exercise. Scientific 
evidence clearly demonstrated that regular moderate-intensity physical activity 
provides substantial health benefits. The current recommendation emphasizes 
the benefits of moderate-intensity physical activity and of physical activity that 
can be accumulated in relatively short bouts, such as five to 10 minutes of 
brisk walking. Existing evidence suggests that amount of activity is more 
important than the specific manner in which the activity is performed. The 
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health benefits of physical activity appear to accrue in approximate proportion 
to the total amount of activity performed, measured as either caloric 
expenditure or minutes of physical activity (Pate et al., 1995). Therefore, in 
this study, rather than measure the type of activities, the amount of activities 
performed were measured. 
Physical activity has been demonstrated to have optimal protective 
effects against a number of chronic conditions, including stroke, coronary heart 
disease (CHD), diabetes, osteoporosis, colon cancer and even breast cancer risk 
(U.S. Congress, Office of Technology Assessment, 1992). Recently it was 
proposed that physical activity may be beneficial to menopausal symptoms 
(Gannon, 1988). Although the empirical support for advocating physical 
activity as a treatment alternative for menopausal symptoms is scarce, there 
are theoretical justifications which warrant its serious consideration and 
investigation. 
Theoretical Speculations 
The beneficial effects of physical activity on perimenopausal symptoms 
may be achieved through several pathways. Holders of the biomedical 
perspective on menopause believe that symptoms around menopause are 
caused by estrogen deficiency. However, recent research has posed serious 
threats to this belief since prepubertal girls and women with primary 
amenorrhea do not experience hot flashes (Rebar, 1987). In addition, past 
studies have not been able to find a significant correlation between hot flashes 
30 
and plasma levels of estrogen (Ballinger, 1987; Hunter, 1988; Maddock, 1978; 
Casper, Yen, & Wilkes, 1979). In contrast, the absence of hot flashes is 
notable in women with low estrogen levels. For example, Martin and colleagues 
( 1 993) found that elevated FSH and lowered levels of estrogen were shown in 
perimenopausal women without vasomotor symptoms. They concluded that 
lack of symptoms during the perimenopausal transition was not attributable to 
a difference in endocrinology. 
Currently, it is proposed that hot flashes are caused by thermo regulatory 
instability which is the result of a loss of ovarian function and the 
accompanying reduction in hypothalamic opioid tone (Greendale & Judd, 1993) 
(see Figure 2). Endogenous opioids regulate the major thermoregulatory 
nucleus and the release of GnRH (hypothalamic gonadotropin releasing 
hormone). In premenopausal women, adequate levels of ovarian steroids 
maintain the endorphin levels. However, with menopause and decreasing levels 
of estrogen and progesterone, endogenous opioids may decrease and cease to 
regulate GnRH and maintain thermal homeostasis. Evidence exists that there 
is a significant reduction in endorphin levels in menopausal women (Petraglia 
et al., 1985; Watts et al., 1985). Therefore, a possible mechanism of the 
effects of physical activity on perimenopausal symptoms is the release of 
endogenous opiates, specifically, beta-endorphins. 
Regular physical activity has been demonstrated to increase central 
opioid activity, thus promoting thermal regulation. Research studies (McArthur, 
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1985) have indicated that levels of beta-endorphins are increased after 
exercise, similar to how estrogen influences vasomotor symptoms. 
Furthermore, people with higher levels of fitness have higher levels of base 
beta-endorphins than people with lower levels of fitness. Thus it is plausible 
that symptoms such as hot flashes can be minimized or alleviated by physical 
activity. 
Figure 2. 
Theoretical speculations of physical activity on 
perimenopausal symptoms 
Physical activity 
t Beta-endorphins level .t- Psychological stress 
Perimenopausal symptoms relief 
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The second view of perimenopausal symptoms is that there is a link 
between psychological stress and/or depression experienced befpre 
perimenopause and the subsequent reporting of vasomotor symptoms (Hunter, 
1 993). Hunter indicated that psychological symptoms can not be explained by 
hot flashes, however, women who are distressed or under stress might be more 
likely to develop vasomotor symptoms. This relationship has been 
demonstrated with both patients and the general population. Gath and 
colleagues ( 1987), in a cross-sectional survey of 500 middle-aged women, 
found a significant association between psychiatric symptoms and hot flashes. 
Hunter ( 1992), in a prospective study of 36 women, found women depressed 
before perimenopause to be more likely to develop hot flashes three years later 
when they entered perimenopause. 
Ballinger and colleagues ( 1 979) proposed that the impact of life stresses 
might actually lead to catecholamine and estrogen changes and hence 
vasomotor symptoms. This theory was examined in a study of 10 clinically 
depressed and 10 non-depressed menopausal women. They found that 
estrogen concentrations were lower in the depressed group. However, when 
depression was lifted using anti-depressive drugs, the estrogen levels increased. 
Physical activity may be useful in alleviating the perimenopausal 
symptoms since physical activity can be stress-reducing. Physical activity as 
an effective means of symptom relief through stress reduction has been 
evaluated and proven in a variety of disorders (premenstrual disorder, tension 
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depression){cite). In addition, menopausal symptoms seem to respond 
positively to stress reduction therapy. Studies (Germaine & Freedman, 1984; 
Stevenson & Delprato, 1983) have shown that stress reduction methods such 
as relaxation and self-control techniques are beneficial to hot flashes. 
In summary, there are at least two possible pathways through which 
physical activity effects perimenopausal symptoms. This study tested the 
hypothesis that physical activity has a positive influence on perimenopausal 
symptoms. 
Research Studies of Relationship between Physical Activity and 
Perimenopausal Symptoms 
Physical activity as a treatment alternative for menopausal symptoms is 
not a new idea. It has been advocated by health professionals for decades. 
However, the majority of studies on physical activity as a therapeutic approach 
in midlife women have primarily assessed the effects on bone aging and 
cardiovascular degeneration, and rarely assessed for menopausal symptom 
management (Gannon, 1988). Several anecdotal accounts have been published 
which describe exercise as resulting in the alleviation of perimenopausal and 
menopausal symptoms. For example, Leven ( 1993), in a non-data based 
article, suggests that regular moderate exercise can have a positive effect on 
sexuality, although the relationship is not fully understood. Exercise may 
improve an individual's libido and overall sexual satisfaction. 
A few empirical studies (Wallace, Lovell, Talano, Webb, & Hodson, 
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1982; Hammar, Berg, and Lindgren 1990; Wilbur, Dan, Hedricks, & Holm, 
1 992) in the literature have examined the relationship between physical activity 
and menopausal symptoms (see Appendix E). Wallace and colleagues ( 1982), 
in a study of pre- and postmenopausal women before and after an aerobic 
conditioning program, found that postmenopausal women experienced a 
reduction in vasomotor symptoms and that estrogen levels increased in both 
pre- and postmenopausal women after the conditioning program. The 
weakness of this study was that it evaluated the short-term effects of an 
exercise session or program without controlling subjects' prior fitness levels 
which would have an impact on the physiological, psychological, and behavioral 
effects of exercise. Small sample size may also undermine the study result. 
Wilbur et al., (1992) in a study of 279 midlife women, found a 
significant positive relationship between occupational energy expenditure and 
vasomotor symptoms and general health. However, there was a negative 
correlation between leisure time physical activity (as measured by energy 
expenditure) and overall symptom reporting. The problem with this study was 
that it used women from the general population. These women may not have 
been physically active at all. Therefore, the sample may not have been 
adequate to test the relationship between physical activity and symptoms 
during perimenopause. 
Hammar, Berg, and Lindgren (1990) investigated the relationship of 
frequency of moderate and severe hot flashes to physical exercise. A control 
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group of 1 246 women aged 52 and 54 year old in Sweden was compared with 
a study group {n = 142). They found that moderate and severe psychosomatic 
symptoms of hot flashes and sweating were only half as common among the 
physically active postmenopausal women (21.5%) as in the control group 
(43.8%). The limitation of the study is that the levels of physical activity in the 
control group were not measured, therefore, some of the women in the control 
group may also have been physically active. In addition, this study did not 
measure the body mass index which may serve as a confounding variable, since 
adipose tissue, which converts adrenal androgens to estrogens, may alleviate 
menopausal symptoms, and consequently, women with a high body mass index 
may be less likely to have menopausal symptoms. Whether or not there was 
a true difference in body mass between the two study groups is not known. 
The current study controled this confounding variable using a statistical 
method. 
In summary, the effectiveness of physical activity on perimenopausal 
symptoms is promising but needed further empirical evaluation. Previous 
studies had not examined the possible benefits of long-term regular physical 
activity on the subsequent risk of occurrence of perimenopausal symptoms. 
The majority of physical activity research evaluates the level of current physical 
exercise or a short term exercise session. Gannon (1988) indicated that even 
if a hormone is found to increase from pre to postexercise, it does not 
necessarily indicate that the basal level of such a hormone will respond in the 
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same manner to a regular physical activity pattern or exercise program. In 
addition, a history of recent physical activity is closely related to overall general 
health (Shinton & Sagar, 1993). Thus the relation between perimenopausal 
symptoms and recent exercise can be confounded by illnesses. A regular 
physical activity pattern was examined in this study in order to minimize this 
threat to design validity. 
Further, research in the past has suggested that the strenuous exercise 
required of professional athletes may lead to a reduction of estrogen levels in 
normally menstruating women (Gannon, 1988). In order for the results of this 
study to be of practical import and realistic for most women, physical activity 
of moderate to vigorous intensity was studied. Therefore, the proposed study 
evaluate the influence of long term, regular, moderate and vigorous intensity 
physical activity on perimenopausal symptoms. 
Demographic Influences 
Demographic factors such as social class, years of education, 
employment status, marital status and social network have been the focus of 
a number of studies with interesting and disparate findings. Wasti, Robinson, 
Akhtar, Khan, and Badaruddin (1993), in a study of 650 women with natural 
menopause, found that women from a higher socioeconomic status reported 
more depressed moods than middle class women and those who lived in slums. 
The authors explained that perhaps the middle and lower class individuals 
overlooked minor symptoms when faced with major socioeconomic problems. 
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In contrast, British studies have found that working class women 
generally report more symptoms than middle class women during 
perimenopause (Bebbington, Hurry, & Tennant, 1981; Hunter, 1992). Holte 
and Mikkelsen (1991) reported that women's depressed moods were more 
common among those who had lower monthly incomes. 
Years of education in middle aged women have been demonstrated to be 
inversely correlated with symptoms during perimenopause (McKinlay, McKinlay, 
& Brambilla, 1987; Dennerstein et al., 1993). For example, Dennerstein et al. 
( 1993), in a study of 2000 women between 45 and 55 years, found, with 
increasing years of education, women reported fewer psychological symptoms, 
better self-rated health, using fewer non-prescription medications, the absence 
of chronic health conditions, a low level of interpersonal stress, the absence of 
premenstrual complaints, not currently smoking, and had positive attitudes 
toward aging and menopause. 
Unemployment has also been shown to contribute to the incidence of 
symptoms during menopause (Hunter, 1992). Midlife women who work (i.e., 
have a paying job) are more likely to be fired, laid off or leave voluntarily when 
compared to men. Crowley ( 1 991 ) suggests that people who lose their jobs 
often experience a type of grief reaction followed by depression. Furthermore, 
older workers who are laid off are unattractive to subsequent employers, being 
close to the end of their working lives (Crowley, 1991 ). Perhaps lack of job 
security and difficulty in employment are also factors noted in the greater 
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incidence of depression in menopause. 
Similarly, Roy ( 1987) indicated that women who lack any form of full or 
part-time employment outside the home are more likely to suffer depression in 
the presence of stressful life events or difficulty. Jennings and colleagues 
( 1 984), in their cross-sectional study, found that while unemployed women 
were the least healthy, full-time homemakers reported worse emotional health 
than employed women. Perhaps lack of financial independence is also an 
important factor in the occurrence of depression in menopause. 
In addition, recent studies have found that menopausal women who are 
divorced, widowed or separated are more likely to be depressed, followed by 
married women, with single women having the fewest problems (Hunter, 1990; 
McKinlay, McKinlay, & Brambilla, 1987). In general, studies of marital, 
employment and socio-economic status have produced mixed results, probably 
because these variables interact in complex ways. For example, in the 
Massachusetts study (McKinlay et al., 1987), there was an interaction between 
years of education and marital status, with the less educated women who were 
divorced or separated being most prone to depressed moods. Therefore, the 
interactions among psychosocial variables need to be considered. In this study, 
data on demographic variables were collected and analyzed as covariates. 
Levels of estrogen have been related to the percentage of body fat since 
adipose tissue is one source of estrogen. In order to investigate the 
relationship between physical activity and perimenopausal symptoms, the 
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percent of body fat should be taken into consideration. In this study, body 
mass index was used to estimate the percentage of body fat. 
The Aims of the Study 
The aims of the study were: 
1 . 
2. 
3. 
a. 
b. 
a. 
To describe the frequency of symptoms in perimenopausal 
women. 
To describe the distress of symptoms in perimenopausal women. 
To evaluate the effect of current physical activity on the 
frequency of perimenopausal symptoms. 
b. To evaluate the effect of current physical activity on the distress 
of perimenopausal symptoms. 
a. To evaluate the effect of long term physical activity on the 
frequency of perimenopausal symptoms. 
b. To evaluate the effect of long term physical activity on the 
distress of perimenopausal symptoms. 
Operational Definitions 
1 . Perimenopause: 
is defined as experiencing changes in menstrual pattern such as irregular 
menstruation or no menstruation for 3 to 11 months. 
2. Physical activity: 
is any bodily movement produced by skeletal muscles that results in 
energy expenditure. 
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3. Exercise: 
is a subset of physical activity defined as planned, structured, and 
repetitive bodily movement done to improve or maintain one or more 
components of physical fitness 
4. Moderate physical activity: 
is an activity performed at an intensity of 3 to 6 METs (work metabolic 
rate/resting metabolic rate)-the equivalent of brisk walking at 3 to 4 mph 
for most healthy adults. Examples include briskly walking (3-4 mph); 
cycling for pleasure or transportation ( < 10 mph), moderate effort 
swimming, general calisthenics, table tennis, golf (pulling cart or carrying 
clubs), fishing (standing/casting), leisurely canoeing (2.0-3.9 mph), 
painting (home repair), mowing lawn (power mower). 
5. Vigorous physical activity: 
is an activity performed at an intensity of 6 or more METs. Examples 
include briskly walking uphill or with a load, fast or racing cycling ( > 10 
mph), fast treading or crawl swimming, stair ergo meter, ski machine 
conditioning exercise, singles tennis, racketball, fishing in stream, rapidly 
canoeing ( > 4 mph), moving furniture, mowing lawn (hand mower). 
6. Currently active: 
individuals who accumulate 1 50 minutes or more of moderate to 
vigorous-intensity physical activity per week during the past month. 
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7. Currently relatively active: 
individuals who accumulate 30-149 minutes of moderate to vigorous-
intensity physical activity perweek during the past month. 
8. Currently inactive: 
individuals who do none or less than 30 minutes of moderate and 
vigorous physical activity per week during the past month. 
9. Long-term active: 
individuals who accumulate 1 50 minites or more of moderate to vigorous 
physical activity per week over the past 10 years 
10. Long-term inactive: 
individuals who do none or less than 30 minutes of moderate to vigorous 
physical activity per week over the past 5 years. 
11. Long-term relatively active: 
individuals who were not belonging to either long-term inactive or long-
term active group. 
CHAPTER Ill 
METHODS 
Sample 
The sample consisted of perimenopausal women who were participants 
in Women Take Heart, a community-based study evaluating women's risk of 
coronary heart disease. Using the power analysis model, to detect an R2 of at 
least 15% with 7 predictor variables (physical activity, age, years of education, 
employment status, marital status, social class and BMI) (beta= .20; power 
= .80; alpha = .05), a minimum of 88 women were necessary for the study. 
Selection Criteria 
Subjects included women who were perimenopausal and aged 40 and 
above. Perimenopause was defined as experiencing changes in menstrual 
pattern which includes menstrual irregularity or no menstruation for three to 11 
months. Using only the perimenopausal women as subjects, it was possible to 
separate the effect of physical activity from that of menopausal status on 
symptoms associated with perimenopause. Potential subjects were excluded 
from the study if they: had a history of hysterectomy and/or bilateral 
oophorectomy; were currently pregnant; were currently or previously on 
hormone replacement therapy; have been on oral contraceptives within the past 
five years. Professional athletes were also excluded from the study since 
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intense training, or overtraining, consistently results in increased mood 
disturbance (Raglin, 1990). In addition, intense training may result in 
amenorrhea. 
Design 
The design was a cross-sectional, correlational, one factor design with 
three levels for the factor. The factor was the levels of physical activity. Three 
groups of women were studied: inactive, relatively active, and active. The 
dependent variables included perimenopausal symptoms and four subscales of 
the Women's Health Assessment Scale (menstrual change, vasomotor 
symptoms, psychosomatic symptoms, and sexual health). The independent 
variable was the amount of physical activity (level= 3). Covariates included 
age, years of education, employment status, marital status, social class and 
body mass index. 
Measurements 
Menopausal Symptoms 
The Women's Health Assessment Scale (see Appendix F) was developed 
from two sources: The Women's Health Questionnaire (Hunter, 1986) and the 
21-item Kaufert and Syrotuik Symptoms Index ( Kaufert et al., 1 988). The 
Women's Health Questionnaire consists of nine subscales and 35 items to 
assess the following areas: somatic (7 items), depressed mood (7 items), 
cognitive difficulties (3 items), anxiety/fears (4 items), sexual functioning (3 
items), vasomotor symptoms (2 items), sleep problems (3 items), menstrual 
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problems (4 items), and attractiveness (2 items). Frequency of the symptoms 
over the past several months was scored on a four-point scale as 0 = "no, not 
at all; 1 = "No, not much"; 2= "yes, sometimes"; or 3= "yes, definitely". 
The concurrent validity of the questionnaire was reported to be .80 and test-
retest reliability was .86 (Hunter, 1986). The strengths of the questionnaire 
include that it measured 1) depressed mood which is more menopause-related 
than clinical depression; and 2) the sexual health of perimenopausal women. 
The 21-item Kaufert and Syrotuik Symptoms Index assesses four areas: 
vasomotor (2 items), genitourinary (3 items), psychologic (6 items), and general 
health symptoms ( 10 items) ( Kaufert & Syrotuik, 1981). Frequency of the 
symptoms over the past several months is scored on a three-point scale as 0 = 
"never"; 1 ="sometimes"; or 2= "often". The questionnaire has been used 
in a number of previous studies of midlife women (Kaufert, 1988; Wilbur et al., 
1 992). Wilbur et al. ( 1 992) found that the questionnaire was reliable and the 
six nervous symptoms were positively related to the Center for Epidemiological 
Studies' Depression Scale. 
In summary, although The Women's Health Questionnaire (Hunter, 1986) 
and the 21-item Kaufert and Syrotuik Symptoms Index are reliable tools to 
measure menopausal symptoms; however, they lack two important 
components which are critical for perimenopausal women. First, they do not 
measure to what degree perimenopausal symptoms upset or distressed midlife 
women. Second, they do not measure menstrual problems that perimenopausal 
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women may experience. Therefore, the Women's Health Assessment Scale 
which does address these areas was developed for this study. 
When developing the Women's Health Assessment Scale, items from the 
Women's Health Questionnaire and the 21-item Kaufert and Syrotuik 
Symptoms Index (Kaufert et al., 1988) were compiled. When items from those 
two instruments were similar, one was selected. In addition, five items 
concerning the menstruating problems which frequently occurred during 
perimenopause were added to the questionnaire. The final questionnaire, the 
Women' Health Assessment Scale, consists of 47 items. In relation to the 
symptom aspect of the new tool, both frequency and degree of distress or 
bothersomeness were rated. Frequency of the symptoms over the past several 
months was scored on a five-point scale as 0 = "never", 1 = "rarely", 2 = 
"sometimes" 3 = "often", or 4 = "always". Degree of bothersomeness or 
distress of symptoms was also scored on a five-point scale as 0 = "not at all", 
1 = "a little", 2 = "moderately", 3 = "quite a bit", or 4 = "extremely". Scores 
were averaged for each dimension separately. The sum of scores on all items 
for each dimension was used to indicate the total perimenopausal symptom 
frequency and distress scores. The score on items of each subscale were 
summed to indicate total subscale scores. Face and content validity of 
Women's Health Assessment Scale were established for the modified tool by 
a panel of five experts. Cronbach's alpha was used to determine internal 
consistency. The strengths of the Women's Health Assessment scale included 
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that it contains the measurements of 1 ) frequency and degree of 
bothersomeness or distress of perimenopausal symptoms and 2) occurrence of 
menstrual symptoms. Therefore, it is more applicable to perimenopausal 
women. 
Physical Activity 
A Physical Activity Questionnaire (see Appendix F) was developed based 
on the physical activity questionnaire in Sturgeon and colleague's study 
(Sturgeon et al., 1993). The Physical Activity Questionnaire consisted of two 
dimensions: current and long-term physical activity. Items estimating activity 
level on each of two aspects: moderate and vigorous activity were included. 
Current activity measured the amount of moderate to vigorous activity during 
the past month. Long-term activity measured the regular activity pattern which 
included the dose and duration of activity. Scores were averaged for each 
dimension separately to give subscale measures of moderate and vigorous 
physical activity. The long-term averages on each dimension were summed to 
indicate total regular physical activity. 
American Heart Association Physical Activity Questionnaire (AHAPAQ) 
measures physical activity pattern on a 5-point scale with 0 =inactive and 
4 =highly active. AHAPAQ was used to evaluate the construct validity of the 
Physical Activity Questionnaire for this study. 
Demographic Variables 
Demographic variables including age, years of education, employment 
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status, marital status, and BMI were measured using a data collection tool 
addressing demographic information and health history (see Appendix F). 
Procedure 
After receiving Institutional Review Board approval (see Appendix G), a 
pilot study was conducted before the actual study began to evaluate the 
reliability of the tools. Seventy-two nursing faculty and staff were contacted 
in order to obtain the pilot sample of 22. A cover letter (Appendix J) explaining 
the purpose of the study and a survey packet, which included questionnaires 
and a stamped and addressed envelope for returning the questionnaires, were 
mailed to all potential subjects. In the cover letter, women were asked to 
participate in the study and informed that their consent to be subjects would 
be indicated by their completion and return of the questionnaire. 
Twenty-two completed questionnaires were returned. The age of the 
subjects ranged from 41 to 55 years, with a mean age of 48.2 years (sd = 3.8). 
Twenty (91 %) subjects were white, one Black (4.5%) and one Hispanic 
(4.5%). The subjects weighed an average of 169 pounds (sd = 33.3; range = 
127 to 238 pounds). All subjects were undergoing perimenopause. 
Content validity of the questionnaires were evaluated by five content 
specialists (three menopause researchers, one exercise expert and one tool 
development expert). A few item-modifications were made before the pilot 
study. 
The reliability of the tool was determined based on internal consistency. 
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Cronbach's alpha for both dimensions of the Women's Health Assessment 
Scale met the accepted standard of . 70 indicating the homogeneity reliability 
of the scale (the Cronbach alpha was .94 for symptom frequency and .91 for 
symptom distress. There were 47 items in each dimension. 
Cronbach alpha for the physical activity questionnaire (Cronbach 
alpha=. 61 and number of items= 10) did not meet the standard for 
homogeneity reliability evaluation which may be explained by the small number 
of items on the tool. Multicollinearity was not found to be a problem as 
indicated by few inter-item correlations greater than . 70. 
Based on the results of the pilot study, no changes were made to the 
WHA questionnaire. Four items describing the type of activity were added to 
the physical activity questionnaire. 
After the reliabilities of the tools were established, database for the 
Women Take Heart program was used to obtain the names, phone numbers, 
and addresses of the perimenopausal women. Then, a cover letter (Appendix 
H) explaining the purpose of the study and a survey packet, which included 
questionnaires and a stamped and addressed envelope for returning the 
questionnaires, was mailed to all potential subjects. In the cover letter, women 
were asked to participate in the study and informed that their consent to be 
subjects would be indicated by their completion and return of the questionnaire. 
Three weeks after the initial mailing, if no response was received, follow-up 
telephone calls were made. A second mailing was made to potential subjects 
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who: 1) were reached by telephone and indicated they were willing to 
participate, but either never received the first questionnaire packet or mislaid 
it, and 2) were not successfully reached by telephone. Twenty percent of the 
perimenopausal women who did complete and return their questionnaires, were 
requested to complete the same questionnaire two weeks later for the purpose 
of test-retest reliability analysis (see Appendix I). A total of 35 women were 
retested. 
Data Analysis 
Data analysis techniques specific to each research question of the study 
are listed below. Internal consistency for each tool was determined by 
Cronbach alpha. The significance level was set at p < 0.05. 
AIM 1. To describe the frequency and associated distress of symptoms in 
perimenopausal women. 
Descriptive statistics were used to describe demographic information and 
the frequency and degree of distress or bothersomeness of perimenopausal 
symptoms. 
AIM 2. To evaluate the influence of current physical activity on the frequency 
and distress of perimenopausal symptoms. 
To accomplish this aim, two steps were used. First, perimenopausal 
symptoms (total score for each dimension) were used as a single dependent 
variable and an ANCOVA with covariates were performed. Second, MANCOVA 
with covariates was used to detect differences on four subscales in three 
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different groups. 
Before the ANCOVA was used, the statistical assumptions were checked 
before any test. For ANCOVA procedure, as a first step, a check was made to 
determine if significant interactions between each of the covariates and the 
independent variable on perimenopausal symptoms (total score for each 
dimension). All covariates, and significant interaction terms were entered in 
the analysis. If a significant F-test for any of the covariates was found it would 
indicate a significant effect for that particular term on perimenopausal 
symptoms. The terms in each covariance model were trimmed to eliminate 
non-significant elements. 
When applying the MANCOVA model, significant interactions between 
each of the covariates and the independent variable on each dimension of 
perimenopausal symptoms were also examined. Assuming equal slopes of a 
given covariate on perimenopausal symptoms in each of the cells of the design, 
a more complex analysis of covariance was undertaken as appropriate. All 
covariates, and significant interaction terms were entered in the analysis. 
Similar to ANCOV A, a significant F-test for any of the covariates would indicate 
a significant effect for that particular term on perimenopausal symptoms. The 
terms in each covariance model will be trimmed to eliminate non-significant 
elements. 
AIM 3. To evaluate the effect of long-term physical activity level on the 
frequency and distress of perimenopausal symptoms 
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Analysis methods used in AIM 2 were used for this aim. 
Potential Risks 
To pretect individuals from the threat of loss of confidentiality, code 
numbers were assigned to each subject. Only the study code number appeared 
on the questionnaires and records. A master list of names, addresses, and 
code numbers was maintained in the event that follow-up was needed. But 
this list was available only to the investigator and will be destroyed when the 
study was completed. There were no any other known risks involved in this 
study except the time and invonvenience required for completion of the 
questionnaires. 
Limitations of the Study 
1 . This study was limited by its cross-sectional design since long-term recall 
was involved, the study results might be limited by recall bias. 
2. There were no objective measures used in this study. It relied on the 
self-report of the women subjects. The use of only self-report data to 
examine physical activity behaviors and symptoms may present some 
threat to internal validity. Each individual's perception may play a role 
in her response to the questionnaire. There was the possibility that 
some respondents reported their behaviors more as they think it should 
have been rather than as it was. 
CHAPTER IV 
RESULTS 
Profile of the Sample 
Of the 840 questionnaires distributed to women aged 40 to 55 years, 
424 were returned, with a response rate of 51 %. When women who 
participated in the pilot study were included, 35. 7% (n = 159) were 
premenopausal, 5.8% (n=26) postmenopausal, 10.5% (n=47) were taking 
hormones or oral contraceptives. This left 214 usable responses. To ensure 
complete data, women were contacted by phone to complete unanswered 
questions and to verify responses when necessary. Therefore, missing data 
were minimal. For Women's Health Assessment Scale, serial means were used 
for the missing data points. For the Physical Activity Questionnaire, subjects 
with missing data were deleted analysis by analysis. 
The report of the results are divided into two sections: psychometric 
analysis of instruments and findings relative to research questions. 
Psychometric Analysis of Instruments 
The total sample (n = 214) was used to establish internal consistency 
reliabilities on the instruments. Measurements of internal consistency reliability 
were made on all of the instruments in this study. Cronbach alphas were 
computed for each subscale within the instruments. The test-retest method 
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was used to determine the stability reliability (repeatability) of the instruments. 
Women's Health Assessment Scale (WHAS) 
Symptom frequency dimension of WHAS 
The items measuring symptom frequency on the WHAS scale were 
analyzed for internal consistency reliability. The Cronbach alpha for the 
symptom frequency (47 items) for the entire sample was .91. The internal 
consistency reliabilities for the subscales for the entire samples are presented 
in Table 2. It should be noted that an extremely high alpha coefficient is not 
necessarily desirable since this would indicate that items are too similar and 
thus, redundant (Cattell, 1978). 
To assess the possibility of redundancy, the inter-item correlations were 
analyzed. There were only a few correlations greater than . 70 indicating 
redundancy is less likely a problem. The high crobach alphas for total scale and 
psychosomatic scale may be explained by the greater number of item in those 
scales. 
The homogeneity reliability was also analyzed by correlating subscale 
scores with the total scale score (Hinshow and Atwood, 1982). All the 
subscales were significantly correlated with the total scale (all P values < .00; 
r = .31 to .97) indicating the contributions of the subscales to the total scale 
(see Table 3). The psychosomatic subscale contributed the most while the 
vasomotor symptoms did the least to the the total scale. 
The subscale scores were further correlated with each other to 
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investigate possible overlap between the subscales. The correlation 
coefficients ranged from low to moderate (r = .07 to .38) (see Table 4). The 
highest correlation coefficients were between psychosomatic symptoms and 
sexual health. 
Table 2. 
Homogeneity reliability: WHAS 
(n = 214) 
Scale/subscale Cronbach's alpha 
Symptom Frequency 
total score 0.91 
vasomotor symptoms 0.49 
psychosomatic symptoms 0.92 
menstrual problems 0.19 
sexual health 0.75 
Symptom Distress 
total score 0.92 
vasomotor symptoms 0.55 
psychosomatic symptoms 0.92 
menstrual problems 0.58 
sexual health 0.76 
No of items 
47 
2 
36 
5 
4 
47 
2 
36 
5 
4 
Table 3. 
Correlations between subscale scores and total scale score of symptom 
frequencies of WHAS (n = 214) 
scale correlation P value 
coefficient (r) 
Total score and vasomotor symptoms score 0.30 .000 
Total score and psychosomatic score 0.97 .000 
Total score and menstrual problems 0.45 .000 
Total score and sexual health 0.55 .000 
Table 4. 
Correlation matrix of symptom frequency dimension of WHAS 
Subscale Vasomotor Psychosomatic Menstrual Sexual 
symptoms (r) symptoms (r) problems health 
(r) (r) 
Vasomotor 1 
symptoms 
Psychosomatic 0.22; 0.00 1 
symptoms 
Menstrual 0.07; 0.16 0.35; 0.00 1 
problems 
Sexual health 0.19; 0.00 0.40; 0.00 0.26; 0.00 1 
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Stability reliability was used to examine the extent to which WHAS yields 
similar results with the sample over time. The test-retest method was used to 
determine the stability reliability (repeatability) of the instrument. Thirty-five 
women were retested after two weeks. Spearman's correlation coefficients of 
the test-retest data indicated that the instrument was reliable (total score: 
r = 0.85, p = .000; vasomotor symptoms: r = 0.86 p = .000; psychosomatic 
symptoms: r = 0.83, p = .000; menstrual problem: r = 0. 76, p = .000; and sexual 
health: r = 0.91, p = .000) (see Table 5). All correlations obtained were 
significant at .05. Sexual health was the most stable subscale. Stability 
reliability of the instrument was therefore supported by these results. 
Symptom distress dimension of WHAS 
The same methods were used to analyze the internal consistency and 
repeatability of the symptom distress dimension of the scale. The Cronbach 
alpha for the symptom distress dimension (47 items) was .92. which meets the 
acceptable standard of. 70 cited by Nunnally ( 1978), therefore, demonstrating 
support for homogeneity reliability of this dimension. The correlation 
coefficients of subscale scores and total scale scores ranged from moderate to 
high (.38 to .98) which further supports the homogeneity reliability of this 
dimension (see Table 6). 
The symptom distress dimension of WHAS exhibited no overlapping 
between subscales, as the correlations between subscales ranged from low to 
moderate (r = .10- .42) (see Table 7). The highest correlation coefficients were 
between menstrual symptoms and psychosomatic symptoms. 
Table 5. 
Stability reliability of WHAS 
(n = 35) 
Scale/subscale Correlation (r) 
Symptom frequency 
Total score 0.85* 
vasomotor symptoms 0.86* 
psychosomatic symptoms 0.83* 
menstrual problems 0.76* 
sexual health 0.91 * 
Symptom distress 
total score 0.80* 
vasomotor symptoms 0.83* 
psychosomatic symptoms 0.81 * 
menstrual problems 0.88* 
sexual health 0.91 * 
* p<0.001 
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Table 6. 
Correlations between subscale scores and total scale score of symptom 
distress of WHAS (n = 214) 
Scale correlation P value 
coefficient (r) 
Total score and vasomotor symptoms score 0.38 .000 
Total score and psychosomatic score 0.98 .000 
Total score and menstrual problems 0.53 .000 
Total score and sexual health 0.53 .000 
Table 7. 
Correlation matrix of symptom distress dimension of WHAS 
Subscale Vasomotor Psychosomatic Menstrual Sexual 
symptoms symptoms problems health 
(r; p) (r; p) (r; p) (r; p) 
Vasomotor 1 
symptoms 
Psychosomatic 0.32; 0.00 1 
symptoms 
Menstrual 0.1 O; 0.67 0.42; 0.00 1 
problems 
Sexual health 0.20; 0.00 0.42; 0.00 0.23; 0.00 1 
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The stability reliability of the scale was supported by high correlations 
between test and retest data. All correlations were significant at .05 level 
(total score: r = 0.80, p = 0.000; vasomotor symptoms: r = 0.83, p = 0.000; 
psychosomatic symptoms: r = ,0.81 p = 0.000; sexual problems: r = 0.88, 
p=0.000, and sexual health: r=0.91, p=0.000) (see Table 5). Again, the 
sexual health was the most stable subscale. 
Physical Activity Questionnaire (PAQ) 
The items measuring physical activity, both current and long-term, were 
included in the analysis of internal consistency reliability (only items with same 
levels of measurement were included; n = 4). The Cronbach alpha was 0. 79. 
The correlations between total score of physical activity questionnaire 
and current and long-term score were high (.95 and .95, respectively) further 
supporting the homogeneity reliability of the scale. The current and long-term 
physical activity were also highly correlated (r = 0.81 ;p = .00) indicating that the 
current physical activity may be reflecting a long-term physical activity pattern. 
It was possible that women who were currently active have also been long-
term active. 
The stability reliability of the physical activity scales are presented in 
Table 8. All correlations obtained were significant at .05. Stability reliability 
of the instrument was therefore supported by these results. It is interesting to 
note that long-term activity was more stable than current activity and also more 
stable than American Heart Association Physical Activity Questionnaire. For 
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both current and long-term activity, vigorous activity was more stable than 
moderate activity. 
Table 8. 
Stability reliability of Physical Activity Questionnaire 
(n = 35) 
Scale/subscale Correlation (r) 
Current physical activity 
Total score 0.79* 
vigorous PA 0.81 * 
moderate PA 0.60* 
Long-term physical activity 
total score 0.92* 
vigorous PA 0.85* 
moderate PA 0.73* 
American Health PAO 0.82* 
* p<0.001 
Validity of the Physical Activity Questionnaire was evaluated by its 
correlation with the AHAPAQ. The correlations for total scale and each 
dimension were all significant at 0.001 level (see Table 9) indicating the 
construct validity of the scale. 
Table 9. 
The correlation between the Physical Activity Questionnaire and the 
American Heart Association Physical Activity Questionnaire 
Questionnaires Correlation coefficient 
AHAPAQ and current physical activity 
total score 0.66* 
vigorous PA 0.61 * 
moderate PA 0.46* 
AHAPAQ and long-term Physical activity 
total score 0.56* 
vigorous PA 0.55* 
moderate PA 0.40* 
* All Ps < 0.05 
Study Aims 
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Data were analyzed to describe the frequency and distress resulting from 
symptoms in perimenopausal women. The data were further analyzed to 
evaluate the effect of physical activity on perimenopausal symptoms. The 
statistical significance level for all analyses was set at .05. 
The results are presented in the following order: sample characteristics, 
the frequency and distress of perimenopausal symptoms, the effect of current 
physical activity on perimenopause, the effect of long-term physical activity on 
perimenopause and the relationships of quality of life to perimenopausal 
symptoms. 
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Sample Characteristics 
The sample consisted of a total of 214 women, 40-55 years of age, all 
of whom were undergoing perimenopause. White women were predominant 
in the study, compared to other ethinic groups (89. 7%, n = 192; 10.3%, n = 22 
respectively). The mean age of the sample was 47 yrs (sd = 3.0). One hundred 
and fifty six women (72.9%) were married, four separated (1.9%), six 
widowed (2.8%), and twenty-one (9.8%) never married and twenty-six 
( 12.1 %) divorced. The majority of women received (97%; n = 206) high school 
or higher education. About 88% of the women (n = 188) were employed; 12% 
(n = 26) were not working at the time of the study. Demographic 
characteristics based on current levels of physical activity are detailed in Table 
10. 
Aim 1 . Frequency and Distress of Perimenopausal Symptoms 
Prevalence 
Hot flashes which are generally considered as one of the most common 
perimenopausal symptoms occurred in 45.8% of the women with 37.3% 
reporting the hot flashes as distressful. However, only 13% of the subjects 
reported experiencing hot flashes often or always and only 14% reported that 
hot flushes were quite a bit or extremely distressful. Hot flashes were not the 
most frequent or distressful symptom reported. The most frequently occurring 
symptoms were reported to be irregular menstrual flow (86.4%), lack of energy 
(74.6%), forgetfulness (67%), irritability (64.8%), stiff joints (62.1 %), 
Table 10. 
Demographic characteristics of the sample 
(N=214) 
Group 
Variable Inactive Relatively Active 
(n=59) active (n = 69) (n = 68) 
Age (yrs) 47.17 (3.3) 47 (2.6) 46. 72 (3.3) 
mean (sd) 
Height (inch) 64.46 (2.2) 64.8 (2.6) 64. 79 (2. 5) 
mean (sd) 
Weight (kg) 183.95 (49.6) 159.42 (36.1) 156.06 (36.8) 
mean (sd) 
Race(%) 
White 82.8 91.3 94.1 
Non-white 17.2 8.6 5.8 
Education (yrs) 
< 13 32.8 18.8 23.5 
13-16 46.6 49.2 51.4 
> 16 20.7 31.9 25.0 
Marital status (%) 
Never married 8.6 11.6 11.8 
Married 77.6 71.0 70.6 
Separated 3.4 0.0 0.0 
Divorced 6.9 14.5 16.2 
Widowed 3.4 2.9 1.5 
Job Status (%) 
Working 93.2 89.9 82.4 
Not working 06.8 10.1 17.6 
Income 
< $20,000 86.2 1.5 4.7 
$20,000-100,000 13.7 84.9 83.6 
> 100,000 0 13.6 12.5 
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difficulty concentrating (58%), bloated stomach (57%), decreased sexual desire 
(57%), breast tenderness (56%), and excessive bleeding (54%). The 
symptoms reported to be most distressful were irritability (54.8%), lack of 
energy (61.4%), forgetfulness (60%), pain and stiffness of joints (51 %), 
headache (53%), difficulty concentrating (53%), bloated stomach (51 %), 
irregular menstrual flow (69.4%) and excessive bleeding (50%). 
Overall scores and subscale scores 
WHAS measures the frequency and distress of perimenopausal 
symptoms. The symptom frequency scores were computed by dividing the 
frequency scores for the total scale and for each subscale by number of items. 
The possible range of scores for this method of computation was 0-4. The 
mean overall frequency score for all symptoms for the sample was 1 . 11 
(sd=0.47; range=0.11-2.49) indicating that the perimenopausal women 
experienced symptoms rarely to sometimes. Mean frequency scores for the 
four subscales were as follows: Vasomotor symptoms, 0.89 (sd = 0. 78; 
range= 0-4); psychosomatic symptoms, 1. 13 (sd = 0. 55; range= 0.03-2. 78); 
menstrual problems, 1.26 (sd =0.56; range =0-2.8), and sexual health, 0.97 
(sd=0.84; range=0-3.5). Thus, overall, the perimenopausal symptoms 
occurred rarely to sometimes and the menstrual symptoms occurred more 
frequently than other types of symptoms. 
The five most frequently reported symptoms on a 0-4 scale were: 1) 
irregular menstrual flow (mean= 2.08 on a 0-4 scale, sd = 1.21), 2) lack of 
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energy (mean= 1.98; sd = 1.12), 3) irritability (mean= 1.82; sd = 1.00), 4) stiff 
of joints (mean= 1. 79; sd = 1.25) and 5) forgetfulness (mean= 1. 77; sd = 1.04). 
The five least reported symptoms were 1) anxiety leaving the house alone 
(mean=0.23; sd=0.59), 2) loss of appetite (mean=0.30; sd=0.64), 3) 
bladder infection (mean= 0.32; sd = 0.68), 4) persistent cough (mean= 0.41; 
sd = 0.85) and 5) bleeding from the uterus at any time other than during the 
menstrual period (mean =0.43; sd =0.74). 
Using the same method, symptom distress was computed by dividing the 
distress scores for the total scale and for each subscale by number of items. 
Again, the possible range of scores was 0-4. The mean overall distress score 
for the sample was 1.07 (sd = 0. 57; range= 0-4) indicating, on average, 
menopausal symptoms were a little stressful. Mean distress scores for the four 
subscales were as follows: Vasomotor symptoms, 0.84 (sd = 0.87; range= 0-
4); psychosomatic symptoms, 1.12 (sd=0.63; range=0.03-3.03); menstrual 
problems, 0.95 (sd =0. 71; range =0-3.2), and sexual health, 0.92 (sd =0.93; 
range= 0-4). Thus, all perimenopausal symptoms were a little distressful and 
psychosomatic symptoms were more stressful than the other types of 
symptoms. 
The five most distressful symptoms were: 1) lack of energy (mean= 1.94 
on a 0-4 scale, sd = 1.33), 2) irritability (mean= 1.82; sd = 1.24), 3) 
forgetfulness (mean= 1.81; sd = 1.30), 4) headache (mean= 1.66; sd = 1.33) 
and 5) excessive bleeding (mean= 1.64; sd = 1.50). The five least reported 
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symptoms were 1) loss of appetite (mean= 0. 16; sd = 0.46), 2) anxiety leaving 
the house alone (mean =0.22; sd =0.66), 3) persistent cough (mean =0 .. 36; 
sd = 0.88), 4) deficient amount of menstrual flow with regular periods 
(mean= 0.42; sd = 0.86), and 5) bladder infection (mean= 0.45; sd = 1.01 ). 
Overview of the Effect of Physical Activity on Perimenopausal Symptoms 
Descriptive data for physical activity are shown in table 11 . About one 
third of women (34. 7%, n = 68) were currently active and one third were 
physically inactive (30.1 %, n = 59). A quarter of women were performing 
vigorous physical activity at least 60 minutes a week. However, only 13.6% 
(n = 29) had been active for 10 years or more and about 48.1 % had been 
inactive for many years. 
Table 11. 
Descriptive data of physical activity 
Groups N % 
Currently inactive 59 30.1 
Currently relatively active 69 35.2 
Currently active 68 34.7 
Long-term inactive 103 48.1 
Long-term relatively active 59 27.6 
Long-term active 29 13.6 
Prior to examining the effect of physical activity on perimenopausal 
symptoms, the similarities and differences among three groups based on the 
current physical activity for demographical variables were evaluated. Using 
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nonparamatric tests for three independent samples, no significant differences 
were found between the groups for race, working status, marital status, .and 
income. Using one-way analysis of variance, no significant differences were 
found between groups for age. However, there was a significant difference 
between groups for body mass index (f = 10.05; p = 0.0001 ). Using Turkey's 
Honestly Significant Difference (HSD) test to further analyze the locations of 
the differences, it was found that the inactive group had a significantly higher 
body mass index than the relatively active and the active group. There was no 
significant difference in body mass index (BMI) between the relatively active 
and active group. Therefore, BMI was used as a covariant in the analyses. 
The influence of physical activity on frequencies of perimenopausal 
symptoms were examined using ANCOV A for total score and MANCOV A for 
subscales. Tukey's HSD tests were used for group comparisons. BMI was not 
a significant covariate for any of the analyses. 
Aim 2. Effect of Current Physical Activity on Perimenopausal Symptoms 
Women were grouped into inactive, relatively active, and active based 
on their levels of current physical activity. Group membership was determined 
according to the following: inactive < 30 minute of total current activity in a 
week; relatively active: 30-149 minutes of total current activity in a week; and 
active: = or > 150 minutes of total current physical activity in a week. The 
descriptive data are shown in Table 12. The inactive group consistently had 
the highest means among the three groups on both the frequency and distress 
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dimensions and all subscales of perimenopausal symptom subscales. 
The tests of significance are shown in Table 13. There were significant 
differences among groups in frequency and distress of overall perimenopausal 
symptoms (f = 8.86, p = 0.00; f = 6.25; p = 0.00 respectively). The relatively 
active and the active groups had significantly less overall frequency of 
symptoms and distress related to symptoms than the inactive group. However, 
the effect of physical activity seems not to be dose-dependent. The active 
group experienced more symptoms and distress than relatively active group. 
The significant multivariate differences were found only in symptom 
frequency (F = 2.33; p = 0.02) not in symptom distress subscale (see Table 
14). However, univariate tests demonstrated that the differences existed in 
psychosomatic symptoms and sexual health for both the frequency (f = 8.05, 
p=0.00; f=3.42, p=0.03 respectively) and distress (f=5.80, p=0.00; 
f = 3. 74, p = 0.03 respectively) aspects of perimenopausal symptoms (see Table 
15). The inactive group experienced more psychosomatic and sexual 
symptoms and also rated psychosomatic and sexual symptoms as more 
distressful than the relatively active and active groups. Again the relatively 
active group experienced fewer symptoms and less distress than active group. 
No significant differences were found among groups in frequency and distress 
of vasomotor symptoms and menstrual problems. 
Table 12. 
Descriptive data for perimenopausal symptoms based on levels of 
current physical activity 
Scale/subscale Group Sample Mean SD 
size 
Symptom frequency 
total score inactive 59 1.29 0.45 
relatively active 69 0.95 0.44 
active 68 1.16 0.51 
vasomotor inactive 59 1.01 0.80 
relatively active 69 0.76 0.73 
active 68 0.93 0.80 
psychosomatic inactive 59 1.32 0.50 
relatively active 69 0.94 0.49 
active 68 1.17 0.58 
menstrual problem inactive 59 1.36 0.55 
relatively active 69 1.17 0.58 
active 68 1.26 0.52 
sexual health inactive 59 1.16 0.81 
relatively active 69 0.77 0.73 
active 68 1.08 0.96 
Symptom distress 
total score inactive 59 1.24 0.54 
relatively active 69 0.89 0.50 
active 68 1.09 0.61 
vasomotor inactive 59 0.94 0.85 
relatively active 69 0.76 0.85 
active 68 0.84 0.91 
psychosomatic inactive 59 1.30 0.61 
relatively active 69 0.93 0.57 
active 68 1.13 0.65 
menstrual problem inactive 59 1.07 0.72 
relatively active 69 0.87 0.65 
active 68 0.98 0.69 
sexual health inactive 59 1.09 0.98 
relatively active 69 0.69 0.76 
active 68 1.07 1.07 
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Table 13. 
ANOV A for perimenopausal symptoms based on levels of current physical activity 
Symptom frequency Source of DF SS MS F-ratio p 
/distress Variance 
Symptom frequency between groups 2 3.86 1.93 8.86 0.00* 
within groups 193 42.07 0.22 
total 195 45.93 
Symptom distress between groups 2 3.82 1.91 6.25 0.00* 
within groups 193 58.95 0.31 
total 195 62.77 
Table 14. 
Multivariate tests of significance for subscales of perimenopausal symptoms based on 
current physical activity 
Symptom frequency DF Wilks Lambda F p 
/distress 
Symptom frequency (with four 8, 380 0.91 2.33 0.02* 
subscales) 
Symptom distress (with four 8, 380 0.93 1.79 0.07 
subscale) 
........ 
0 
Table 15. 
Univariate tests for subscales of perimenopausal symptoms based on levels of current physical activity 
Symptom frequency /distress OF SS MS F-ratio p 
Symptom frequency 
vasomotor (2, 193) 2.07 1.03 1.72 0.18 
psychosomatic (2, 193) 4.45 2.22 8.05 0.00* 
menstrual (2, 193) 1.10 0.55 1.82 0.17 
sexual health (2, 193) 4.87 2.43 3.42 0.03* 
Symptom distress 
vasomotor (2, 193) 1.04 0.52 0.69 0.51 
psychosomatic (2, 193) 4.32 2.16 5.80 0.00* 
menstrual (2, 193) 1.21 0.61 1.29 0.28 
sexual health (2, 193) 6.61 3.31 3.74 0.03* 
'-! 
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AIM 3. Effect of Long-term Physical Activity on Perimenopausal Symptoms 
Women were divided into three groups based on the levels of long-term 
physical activity. Rules for group membership included: inactive: < 30 minutes 
of physical activity a week for the past five years; active: > 150 minutes of 
activity a week for the past 10 or more years; and relatively active: women not 
belonging to either group. Descriptive data are shown in Table 16. The 
inactive group consistently had the highest means among the three groups on 
both the frequency and distress dimensions and all subscales of perimenopausal 
symptoms. The ANOV A tests for differences among groups on overall 
symptom frequency and distress are shown in Table 17. No significant 
differences were found. The multivariate tests of significance are shown in 
Table 18. There was a significant difference among the means of subscales of 
symptom occurrence (f = 1.98; p = 0.04), but not that of symptom distress. 
Univariate tests demonstrated that the differences existed in psychosomatic 
symptoms (f=3.24, p=0.04) (see Table 19). The inactive group experienced 
more psychosomatic symptoms than the relatively active and active groups. 
Again, the effect of physical activity seems not to be dose-dependent. The 
relatively active group experienced fewer psychosomatic symptoms than the 
active group. There were no significant differences among groups in 
vasomotor, menstrual, and sexual problems. 
Table 16. 
Descriptive data for perimenopausal symptoms based on levels of long-term 
physical activity 
Scale/subscale Group Sample Mean SD 
size 
Symptom frequency 
total score inactive 103 1.21 0.49 
relatively active 59 1.03 0.50 
active 29 1.13 0.48 
vasomotor inactive 103 0.88 0.78 
relatively active 59 0.88 0.82 
active 29 1.17 0.74 
psychosomatic inactive 103 1.24 0.55 
relatively active 59 1.01 0.55 
active 29 1.13 0.56 
menstrual problem inactive 103 1.28 0.58 
relatively active 59 1.19 0.56 
active 29 1.37 0.53 
sexual health inactive 103 0.95 0.77 
relatively active 59 1.02 0.92 
active 29 0.90 0.90 
Symptom distress 
total score inactive 103 1.15 0.59 
relatively active 59 1.00 0.58 
active 29 1.07 0.57 
vasomotor inactive 103 0.83 0.86 
relatively active 59 0.85 0.90 
active 29 1.05 0.91 
psychosomatic inactive 103 1.22 0.65 
relatively active 59 1.01 0.60 
active 29 1.10 0.63 
menstrual problem inactive 103 0.95 0.71 
relatively active 59 0.95 0.68 
active 29 1.05 0.73 
sexual health inactive 103 0.90 0.92 
relatively active 59 1.02 1.02 
active 29 0.84 0.92 
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Table 17. 
ANOVA for perimenopausal symptoms based on levels of long-term physical activity 
Symptom frequency Source of DF SS MS F-ratio p 
/distress Variance 
Symptom frequency between groups 2 1.17 0.58 2.42 0.09 
within groups 188 45.22 0.24 
total 188 46.39 
Symptom distress between groups 2 0.88 0.44 1.33 0.27 
within groups 188 62.22 0.33 
total 188 63.10 
Table 18. 
Multivariate tests of significance for subscales of perimenopausal symptoms based on levels of 
long-term physical activity 
Symptom frequency DF Wilks Lambda F p 
/distress 
Symptom frequency (with four 8 0.92 1.98 0.04* 
subscales) 
Symptom distress (with four 8 0.96 0.95 0.46 
subscale) 
-..J 
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Table 19. 
Univariate tests of significance for subscales of perimenopausal symptoms based on levels of 
long-term physical activity 
Symptom frequency /distress OF SS MS F-ratio p 
Symptom frequency 
vasomotor (2, 182) 2.02 1.01 1.63 0.20 
psychosomatic (2, 182) 1.95 0.98 3.24 0.04* 
menstrual (2, 182) 0.72 0.36 1.13 0.33 
sexual health (2, 182) 0.39 0.19 0.27 0.76 
Symptom distress 
vasomotor (2, 182) 1.00 0.50 0.63 0.53 
psychosomatic (2, 182) 0.75 0.37 0.96 0.39 
menstrual (2, 182) 0.31 0.15 0.30 0.74 
sexual health (2, 182) 0.81 0.40 0.45 0.64 
....... 
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Additional Findings 
The relationships between perimenopausal symptoms and quality o~ life 
variables were also analyzed. 
The relationship between perimenopausal symptoms and overall quality 
of life 
All aspects of perimenopausal symptoms except frequency of vasomotor 
symptoms were significantly correlated with quality of life (see table 20). 
Multiple regression was used to identify aspects of symptoms which were 
predictable of women's quality of life during perimenopause. It was found that 
the frequency of psychosomatic symptoms was the single significant symptom 
subscale predicting quality of life. The fewer psychosomatic symptoms a 
woman experienced, the better her quality of life during perimenopause. The 
frequency of psychosomatic symptoms as a single factor accounted for 32% 
of variance (see Table 21 ). 
Comparison in quality of life before and during perimenopause 
The quality of life during perimenopause was compared with the quality 
of life before perimenopause, using Wilcoxon matched pairs singed-ranks test. 
Women had significantly decreased quality of life during perimenopause (z = -
6.97; p = 0.00). 
Table 20. 
The correlations between perimenopausal symptoms and 
overall quality of life 
Scale/subscale Quality of Life {r; p) 
Symptom frequency 
total score -0.55; 0.00* 
vasomotor symptoms -0.07; 0.15 
psychosomatic symptoms -0.55; 0.00* 
menstrual problems -0.20; 0.00* 
sexual health -0.30; 0.00* 
Symptom distress 
total score -0.54; 0.00* 
vasomotor symptoms -0.14; 0.02 * 
psychosomatic symptoms -0.54; 0.00* 
menstrual problems -0.21; 0.00* 
sexual health -0.31; 0.00* 
* P<.05 
'I I 
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Table 21. 
Multiple regression of quality of life on perimenopausal symptoms 
Perimenopausal symptoms 
Symptom frequency 
vasomotor symptoms 
psychosomatic symptoms 
menstrual problems 
sexual health 
Symptom distress 
vasomotor symptoms 
psychosomatic symptoms 
menstrual problems 
sexual health 
* P<.05 
R2=32% 
Model: f=12.06; p=0.00 
BETA 
0.06 
-0.55 
-0.02 
0.01 
-0.00 
-0.13 
0.04 
-0.11 
T p 
0.53 0.60 
-9.63 0.00* 
-0.19 0.85 
0.06 0.95 
-0.02 0.99 
-0.76 0.45 
0.52 0.60 
0.71 0.48 
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Summary of Findings 
The following summarizes the important findings of the influence of 
physical activity on perimenopausal symptoms in 214 perimenopausal women: 
1. The Women's Health Assessment Scale and the Physical Activity 
Questionnaires were reliable instruments for measuring perimenopausal 
symptoms and physical activity respectively. 
2. Mean age of perimenopause was 4 7 years. 
3. More than two-thirds of perimenopausal women experienced hot flashes. 
However, only 13.5% experienced the symptom often or all the time and 
only about 14% reported that the symptom was quite a bit or extremely 
distressful. 
4. The most frequent and distressful symptoms were psychosomatic such 
as irritability, lack of energy, forgetfulness, stiff joints, and menstrual 
problems such as irregular menstruation and excessive bleeding. 
5. About one third of women were currently active, one third relatively 
active and one third inactive. Only about 15.2% of the women had been 
active for 10 years or more, and more than one half of the women were 
inactive for over 10 years. 
6. Total amount of weekly physical activity had significant effects on both 
dimensions of perimenopausal symptoms. Relatively active and active 
women had significantly fewer total symptoms, psychosomatic and 
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sexual symptoms than the inactive group. They also experienced less 
distress for psychosomatic and sexual symptoms than the inactive 
group. However, the effect of physical activity was not dose dependent 
because the relatively active group experienced fewer symptoms and 
less distress and the active group. 
7. Long-term physical activity had significant effects on psychosomatic 
symptoms. The relatively active and active group had significantly fewer 
psychosomatic symptoms than the inactive group. Again, the effect of 
physical activity was not dose dependent. The relatively active group 
experienced few psychosomatic symptoms than active group. 
8. Frequency of psychosomatic symptoms was the single significant 
subscale predicting quality of life during perimenopause. This single 
factor accounted for 32% of the variance. 
9. Quality of life was lower during perimenopausal versus premenopausal 
period. 
CHAPTER V 
DISCUSSION 
The primary aim in this chapter is to discuss the findings in two major 
areas: measurement statistics and the findings related to the study aims. 
Recommendations for future research and implications for nursing care are also 
discussed. 
Measurement Statistics of the WHAS and PAO 
WHAS 
Homogeneity reliability is a measurement of the degree to which items 
on the tool are measuring the same attribute. Cronbach's alpha for both 
dimensions of Women's Health Assessment Scale (WHAS) met the accepted 
standard of greater than 0. 70, supporting the homogeneity reliability of the 
scale. Two subscales, psychosomatic and sexual health, for both dimensions, 
also met the standard. 
The low Cronbach's alpha for vasomotor symptoms may be explained by 
the small number of items (items= 2) since the size of the alpha coefficient is 
based on both the average correlation among items and the number of the 
items in the tool. However, the vasomotor subscale did meet the 
recommendation given by Helmstadter (1964) that alpha coefficient of 0.50 
was sufficient for group comparison. 
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It was not surprising that menstrual subscale did not meet the 
homogeneity reliability standard because some items composing the subscale 
were mutually exclusive. For example, if a woman experienced scant 
menstruation, she would not experience excessive bleeding. 
The subscales of WHAS were significantly correlated with the total scale 
for both dimensions, frequency and distress, further supporting the 
homogeneity reliability of the scale. The low inter-subscale correlations 
indicated that the subscales measured differing dimensions and were not 
redundant. 
Stability reliability examines the extent to which the instrument yields 
similar results with same sample over time. The WHAS proved stable as 
shown by the high correlations between test and retest scores for both 
dimensions and all subscales of the tool. 
Homogeneity reliability of the Physical Activity Questionnaire was 
supported by adequate alpha coefficients and substantial correlations between 
the subscales, the current and long-term activity, and total scale. However, the 
inter-subscale correlation was also high which may indicate redundancy 
between subscales or that current physical activity is a reflection of long-term 
physical activity patterns. 
Stability reliability of the physical activity questionnaire was well 
supported by the strong correlations between test and retest scores. The 
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significant correlation between the Physical Activity Questionnaire and the 
American Heart Association questionnaire established the construct validity of 
the physical activity questionnaire. 
In summary, homogeneity reliability coefficients and stability coefficients 
of the WHAS and physical activity questionnaire achieved satisfactory 
standards for reliability. Content validity of the WHAS was adequately 
documented and the construct validity of physical activity was established by 
these data. WHAS fills a void in the instrumentation available for assessing 
perimenopausal symptoms. Future research should focus on replication of the 
psychometric procedures using a larger sample size. 
Study Aims 
This study was designed to examine the influence of physical activity on 
perimenopausal symptoms. The main results are compared with the findings 
of other recent studies. 
Before attempting to interpret the results of frequency and distress of 
perimenopausal symptoms, several important related points should be noted. 
First, the data consisted of self-reported symptoms which were specified in the 
questionnaire but which may have been subject to varying interpretation by the 
respondents. Second, although an opportunity was provided for respondents 
to list further symptoms, this opportunity was seldom taken. Thus, reporting 
was effectively restricted to those symptoms specified in the questionnaire. 
This method of data gathering might lead to over-reporting of the specified set 
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of symptoms and under-reporting of others, thus creating bias in the results. 
Third, in this study, the frequency and distress of each symptom category was 
the average rating of each symptom's frequency and distress on a 5 point 
scale, ie, from never to always, thus the averages of symptoms in this study 
may be artificially high. 
Aim 1 . Frequency and Distress of Perimenopausal Symptoms 
The overall level of symptoms in this group of women as detected by the 
WHAS is comparable with that already noted in studies of women of this age 
group in the general population. In this study of apparently healthy women, the 
mean overall frequency and the mean overall distress score of perimenopausal 
symptoms were 1.11 and 1.07 (ranges, 0 to 4), respectively, suggesting that 
symptoms occurred rarely to sometimes and were a little stressful. This finding 
is in agreement with other community-based studies in North America showing 
that perimenopause was not a major subjective health problem in midlife 
women (Avis, McKinlay, 1991; Kaufert, Gilbert, and Hassard, 1988; Mattews 
et al., 1990; McKinlay et al., 1991). 
Perimenopausal women do experience symptoms and these symptoms 
do seem distressful in a small percentage of women. In this study, it was 
found that the most prevalent symptom was menstrual irregularity. This result 
was expected because menstrual irregularity is a symbol of entering into the 
perimenopausal stage of menopause. Besides menstrual problems, 
psychosomatic symptoms occurred more frequently than sexual and vasomotor 
85 
symptoms. Vasomotor symptoms were the least frequently experienced 
symptoms among the four groups of symptoms. The most distressful 
symptoms were psychosomatic symptoms and the least distressful symptoms 
were vasomotor symptoms. This finding does not support contemporary health 
care view which stresses that women often seek help for vasomotor symptoms 
such as hot flashes. It is possible that some women with vasomotor symptoms 
may have been excluded from this study due to treatment with hormone 
replacement therapy. 
No previous studies have reported the occurrence and distress of 
perimenopausal symptoms using a 5-point scale. So it is impossible to compare 
the means of frequency and distress of perimenopausal symptoms in this study 
to that of others. It is possible, however, to compare the frequency and 
distress of perimenopausal symptoms in physically active to inactive women 
within the present sample. Physically active women experienced fewer overall 
symptoms and less distress. When each symptom subscale (vasomotor, 
psychosomatic, menstrual and sexual health) was broken down into its 
component symptoms, comparisons were made with the findings of other 
studies. 
Vasomotor symptoms 
The prevalence of the occurrence of hot flashes was 45.8%, which is 
comparable with majority of the previous studies in western countries (Mckinlay 
et al., 1992; Jaszman et al., 1969; Hunter, 1992; Koster & Davidsen, 1993) 
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(see Table 3). However, this prevalence is still higher than that reported for 
Australian (Dennerstein et al., 1993) and Canadian women (Kaufert et al., 
1992) (see Table 3). 
The distress associated with vasomotor symptoms has been often 
ignored by other investigators. In this study, it was found that only 14% of 
perimenopausal women reported that hot flashes were quite a bit or extremely 
distressful. For most women hot flashes were in fact relatively easy to cope 
with, probably because they are characteristically short-lived (duration 
approximately 3 minutes) and occurred infrequently in most women. Many 
women were bothered more by the psychosomatic complaints for which they 
often did not have an explanation, and for which they sought medical care. 
This finding is in agreement with findings reported by Oldenhave et al. ( 1 993) 
and Boulet et al. ( 1 994). In their studies, it was found that women suffering 
from psychosomatic complaints were more likely to have consulted their 
physicians than women suffering from hot flashes and night sweating. 
Menstrual problems 
The prevalence of menstrual irregularity (86.4%), the most common 
symptom in perimenopausal women, was consistent with previous studies by 
McKinlay, Brambilla, and Posner ( 1992), Seltzer et al. ( 1990), and Treloar et al. 
(1967). They found that approximately 90% of women experienced menstrual 
irregularity during perimenopausal years, and that only 10-12% of 
premenopausal women will have sudden amenorrhea. 
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Menstrual problems were the second most distressful perimenopausal 
symptom. This finding is consistent with the view of McKinlay et al. ( 1992) 
who indicated that abnormal bleeding can be disturbing, especially if it is heavy 
and unpredictable. These investigators further indicated that irregular menstrual 
bleeding during perimenopause appears to be more worrisome to women than 
hot flashes, particularly if this irregular menstrual bleeding persists beyond a 
year or two. 
Psychosomatic symptoms 
The most frequently experienced psychosomatic symptoms in 
perimenopausal women in this study included irritability (64.8%), forgetfulness 
(67%), lack of energy (74.6%), stiff joints (62.1 %), and headache (54.2%). In 
comparison with those reporting vasomotor complaints, the percentage of 
women experiencing psychosomatic complaints were relatively high. This 
finding is in agreement with previous studies (Dennerstein et al., 1993; Greene, 
1976; Kaufert, Syrotuik, 1981; Mikkelsen, Holte, 1982; Oldenhave et al., 
1993; Holte, 1992; and Boulet, et al., 1994) (see Table 3). The high 
percentages of women reporting psychosomatic symptoms might be an 
indicator of general distress experienced around the perimenopausal years, such 
as the realization that one is aging. When these symptoms are viewed as 
' individual symptoms, irritability, lack of energy and headache are consistently 
among the top five symptoms reported across studies (Dennerstein et al., 
1993; Jaszmann, Van Lith, and Zaat, 1969). The present findings, combined 
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with earlier observations in different countries, suggest that perimenopause is 
mainly associated with psychosomatic symptoms, such as irritability, 
forgetfulness, lack of energy, stiff joints, and headache. 
No previous studies were found which used rating scales to measure the 
distress of psychosomatic complaints. This study found that the 
psychosomatic symptoms were most distressful in perimenopausal women. As 
discussed previously, many women were bothered more by the psychosomatic 
complaints for which they often did not have an explanation and for which they 
sought medical care. This is in agreement with the findings reported by 
Oldenhave et al. ( 1 993) in the Netherlands and by Boulet et al. ( 1994) in seven 
South-East Asian countries. According to a National Ambulatory Medical Care 
Survey (NAMCS) in 1989, symptoms such as headache, neck, shoulder and 
back discomfort, depression, dizziness, anxiety and nervousness, and 
particularly tiredness, exhaustion and fatigue, were ranked in the top 36 
reasons of 60 reasons for visiting physicians mentioned by women patients, 
aged 45 to 64 years. This indirectly suggests that psychosomatic problems 
among this age group are more distressful than vasomotor symptoms. 
Sexual health 
In this study, the prevalence of sexual problems were: decrease in sexual 
desire 57%, vaginal dryness, 53.3%, dissatisfaction, 37.9%, and painful 
intercourse, 27.6%. Yet these women did not rank these sexual problems as 
highly as other perimenopausal symptoms. This is consistent with previous 
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studies or commentaries (Bachman, et al., 1985; Channon and Ballinger, 1986; 
Hunter, Battersby, and Whitehead, 1986) (see table 3). 
The distress associated with sexual problems has seldom been studied. 
This study found sexual problems were less stressful than psychosomatic and 
menstrual complaints, but more stressful than vasomotor symptoms. Sexual 
problems maybe overshadowed by other symptoms such as mood swings and 
menstrual irregularity. The beliefs that sexual decline and dysfunction in 
perimenopausal women are the natural consequences of aging and hormonal 
decline, and that women who maintain interest in sexual activity at levels 
exhibited during their 20s and 30s did not seem to influence the responses 
from the present sample. 
Aim 2. Effect of Current Physical Activity on Perimenopausal Symptoms 
Regular physical activity has long been regarded as an important 
component of a healthy lifestyle. This impression has been reinforced by new 
scientific evidence that physical activity prevents or reduces the incidence of 
cardiovascular disease, obesity, osteoporosis, anxiety and depression (Pate, et 
al., 1995). There is beginning evidence that physical activity may be an 
important contributor to perimenopausal symptom prevention and management. 
Therefore, this study was designed to examine the effect of physical activity 
on perimenopausal symptoms. 
Effect of current physical activity on vasomotor symptoms 
The findings from the present study did not support the notion that 
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physical activity ameliorates vasomotor symptoms. This is consistent with two 
previous studies. Wilbur et al. ( 1992) in a study of 279 midlife women found 
that physical activity measured by energy expenditure did not effect the 
occurrence of vasomotor symptoms. Guthrie et al. ( 1995) in a community 
study of 2000 women also found that the level of physical activity had no 
significant effect on women's experience of troubling symptoms, such as 
vasomotor symptoms. Thus the present study in combination with Wilbur et 
al. and Guthrie et al. seem not to support physical activity as an alternative to 
estrogen replacement therapy for vasomotor symptoms. 
However, in contrast to these findings, Wallace et al. ( 1982) found that 
short-term exercise reduced vasomotor symptoms in menopausal women. 
They tested pre- and postmenopausal women before and after an aerobic 
conditioning program. Fifty-five percent of the postmenopausal women reported 
a decrease in severity of hot flashes and both groups showed a significant 
increase in levels of estrogen. Similar to findings of Wallace et al., Hammar et 
al. ( 1 990) in a study of 1 246 women found that hot flashes and sweating were 
only half as common in postmenopausal women who took part in organized 
physical exercise as compared to the control group. 
The differing findings between the present study and those 
demonstrating that exercise can help vasomotor symptoms can be explained 
by several factors. First, the studies by Wallace et al. and Hammar et al. used 
different study populations than the present study; while Wallace et al. and 
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Hammar et al. used postmenopausal women, the present study used 
perimenopausal women as subjects. The postmenopausal women's responses 
to exercise may be different from those of the perimenopausal women. For 
example, Wallace and colleagues found that exercise which relieves symptoms 
for postmenopausal women was not useful for peri- and premenopausal 
women. 
The second explanation for the discrepancies in findings is that it may 
require higher levels of physical activity to relieve vasomotor symptoms. It 
should be noted that the levels of activity in the studies by Wallace et al. and 
Hammer et al. could have been higher than the physical activity levels in the 
present study. This may also be true of the studies by Wilbur et al. and 
Guthrie et al. The present study also showed a trend that women with higher 
levels of vigorous activity experienced fewer vasomotor symptoms and less 
distress. However, this difference did not reach statistical significance level. 
So it is possible that the level of vigorous activity practiced by women in the 
present study as well as those in the studies by Wilbur et al. and Guthrie et al. 
was not high enough to have a significant effect on vasomotor symptoms. 
The present study not seem to support the view that changed central 
noradrenergic and opioid activity cause hot flashes (Schurz et al., 1 988; 
Shoupe and Lobo, 1987; Sturdee and Brincat, 1988; Tepper et al., 1987). 
Experts suggest that there are several indications of changes in both 
noradrenergic and opioid neuron activities during perimenopause (Shoupe and 
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Lobo, 1 987; Sturdee and Brincat, 1 988); and that P-endorphin has been shown 
to increase after estrogen supplementation (Shoupe and Lobo, 1987). If low 
opioid activity is involved in the mechanisms that elicit the hot flashes, then 
regular physical activity, which is known to increase central opioid activity 
(Cumming and Wheeler, 1987), should diminish the risk of hot flashes. 
However, in this study, the occurrence and severity of the vasomotor 
symptoms was the same for physically active women as for inactive women. 
Again, the possible explanations include that the dose of physical activity was 
not high enough to increase the central opioid activity. Another possible 
explanation might be that the active women had less adipose tissues. Adipose 
tissue converts adrenal androgens to estrogens, which may alleviate 
perimenopausal symptoms. In this study, levels of physical activity were 
significantly correlated with body mass index, which suggest that physically 
active women had less body fat. 
Effect of current physical activity on psychosomatic symptoms 
The present study demonstrated for the first time that moderate amounts 
of physical activity may significantly decrease the occurrence and distress of 
psychosomatic symptoms. The groups who participated in physical activity 
had fewer symptoms than the group who were inactive. The potential 
beneficial effect of physical activity on psychosomatic symptoms is consistent 
with previous studies of physical activity on mortality of cardiovascular 
diseases. Pate et al. ( 1995) in reviewing several studies of physical activity on 
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the relative risk of cardiovascular mortality concluded that the health benefits 
of physical activity appear to accrue in approximate proportion to the ~otal 
amount of activity performed, measured as either caloric expenditure or minutes 
of physical activity (Blair et al., 1989; Ekelund et al., 1988; Leon et al., 1987; 
Morris, et al., 1990; Paffenbarger et al., 1993; Sandvik et al., 1993). 
This finding is also consistent with a number of other studies of physical 
activity in menopausal women. Wilbur et al. ( 1990) found significant negative 
correlations between leisure time physical activity and nervous (tiredness, 
irritability, headache, nervous tension, trouble sleeping and depression) and 
general symptoms (joint pain, backache, diarrhea, upset stomach, cough, et al.) 
in pre-, peri-, and postmenopausal women. Collins and Landgren (1995) found 
that in a Swedish population-based sample of perimenopausal women, negative 
mood was associated with a lack of exercise. 
However, the findings of the present study are inconsistent with one 
recent study. Guthrie et al. (1995), in a random selected community cohort of 
2000 Australian women, found that there were no significant associations 
between levels of physical activity, psychological well-being and women's 
experience of symptoms during the natural menopause transition. The 
discrepancies between the two studies may be explained by the measurement 
of physical activity. In the present study, physical activity was measured as 
the total amount of moderate and vigorous activity. In contrast, Guth ire et al 
( 1995) measured physical activity as daily energy expenditure using the 
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Minnesota Physical Activity Questionnaire which includes light, moderate, and 
vigorous activity. Including the light activity may dilute the effect of moderate 
and vigorous activity on perimenopausal symptoms, because light activity has 
been shown to have no beneficial effects on health. 
Although it appears that there is amelioration of psychosomatic 
symptoms with more physical activity, there is no clear physiological 
explanation for these findings. Fremont and Craighead ( 1987) suggested that 
physical activity may produce increased levels of endorphins which influence 
mood. Raised endorphin levels have been associated with significant reduction 
in depression (Gerner et al., 1980). However, Farrell et al. (1987) found that 
endophins activated by physical activity had no effect on mood alterations. 
Psychological explanations for psychosomatic symptom relief after 
physical activity have been the subject of several reviews (Coverley-Veale, 
1987; Gieser & Mendelberg, 1990; Kirkcaldy & Shephard 1990). Cognitive-
behavioral theory proposes that cognitive distortions and repeated intrusive 
thoughts are major components of psychosomatic symptoms (Beck, 1987). 
Physical activity may act as a distraction from intrusive thoughts, and allow 
positive thoughts to surface, decreasing depression in the short-term. Another 
possible explanation is that physical activity improves body image and self-
efficacy which impacts on self-concept and self-esteem. The increased social 
contact offered by physical activity groups may be particularly relevant. 
However, much of this remains speculative. Thus, so far we can only report 
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that physical activity can alleviate psychosomatic symptoms. 
Although physical activity is beneficial to psychosomatic symptoms, the 
effect is not dose dependent. The relatively active group experienced fewer 
psychosomatic symptoms and distress than the active group. The non-linear 
relationship may be due to the rigid classification of levels of physical activity. 
It is also possible that some active women may have underreported their 
activity and being classified into the relative active group. Further study is 
needed to identify the adequate dose of physical activity for psychosomatic 
symptoms. 
Effect of current physical activity on sexual symptoms 
Another significant finding of this study was the negative relationship 
between levels of physical activity and occurrence and distress of sexual 
symptoms. Sexual health for perimenopausal women has not been well 
studied. Collins and Landgren ( 1995) found that in a Swedish population-based 
sample of perimenopausal women, occurrence of perimenopausal symptoms 
including reduced sexual interest was related to lack of exercise. However, no 
separate analysis for sexual health was done. 
It is not clear how physical activity influences sexual health. A study of 
sexual behavior in exercising men indicated that sexual health was related to 
the level of physical fitness (White, Case, McWhirter, & Mattison, 1990). 
Physical activity can improve physical fitness, thus, help improve sexual health. 
Other data suggest that orgasmic pleasure may increase with increased skeletal 
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muscle tone resulting from physical activity (Mandell, 1979). Another 
explanation may be that physical activity increases women's perceived physical 
attractiveness and, consequently, enhanced sexual health (Holmes, Chamberlin, 
& Young, 1994). 
Effect of current physical activity on menstrual problems 
Menstrual problems during perimenopause have not been well studied. 
In this study, no significant differences were found between the menstrual 
problems reported by physically active and inactive women. 
Previous research has shown that menstrual irregularity such as 
oligomenorrhea or secondary amenorrhea is an infrequent but possible 
consequence of strenuous exercise programs in menstruating women and is 
frequently used as an argument against women engaging in strenuous exercise 
(Bullen et al., 1985; Gannon, 1988). Russell et al. (1984) reported that six 
swimmers who were training intensively up to five hours per day, five days per 
week developed oligomenorrhea; however, all six resumed normal menses 
when training was reduced. This suggests that exercise -induced menstrual 
changes may be temporary. In attempting to clarify the cause of menstrual 
irregularity in athletes, Shangold, Gatz, and Thysen ( 1981) have pointed out the 
necessity of separating the effects of exercise per se, from the effects of the 
physical stress of training and the emotional stress of competing. Schwarz et 
al. ( 1 981) found that amenorrheic runners associated more stress with their 
running than did normally menstruating runners. In the present study, no 
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relationship was found between physical activity and menstrual symptoms. 
One explanation is that the physical activities of this group of women were not 
strenuous enough to cause menstrual dysfunction, and without competition, no 
emotional stress was involved. Thus, it may be concluded that physical activity 
has a variety of beneficial effects and is not associated with potentially harmful 
menstrual changes, particularly in moderate doses. 
AIM 3. Effect of Long-term Physical Activity on Perimenopausal Symptoms 
Long-term physical activity is defined by two independent factors--
weekly amount of physical activity and years of activity performed. Both long-
term and current physical activity were related to perimenopausal symptoms 
in the same way. It is possible that women who are active currently have also 
been active long-term. Total years of physical activity had significant effect on 
perimenopausal symptoms. Women with 10 or more years of moderate and /or 
vigorous activity had significantly less total, psychosomatic and sexual 
symptoms than those with less than 10 years of physical activity. This finding 
further supports the view that long-term physical activity is beneficial to 
perimenopausal health.This finding supports the view that physical activity of 
lifelong continuation is as important, if not more important than recent or short 
term physical activity (Shinton and Sagar, 1993) 
Additional Findings 
Women experience decreased quality of life during perimenopause 
compared to premenopausal stage. This finding is expected because women 
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are generally experiencing more symptoms during peri- than premenopausal 
period. Experience of symptoms such as hot flashes and forgetfulness and the 
distress caused by them would decrease the quality of life during 
perimenopause. 
All aspects of perimenopausal symptoms except occurrence of 
vasomotor symptoms are significantly correlated with quality of life. However, 
using multiple regression analysis, it was found that psychosomatic symptoms 
were the single significant symptom category among the four subscales 
predicting quality of life. The occurrence of psychosomatic symptoms as a 
single factor accounted for 32% of the variance. This indirectly suggests that 
psychosomatic symptoms are important determinants to quality of life in 
perimenopausal women. 
Finally, the more active the woman, the better quality of life. This can 
be explained by the fact that physical activity reduces psychosomatic 
symptoms, the most prevalent and distressful symptoms, among the 
perimenopausal women which lead to better quality of life. 
Conclusions, Implications and Limitations 
In conclusion, perimenopausal symptoms were reported to occur rarely 
to sometimes and, for the majority of women, symptoms were a little 
distressful in a community-based population. Among these symptoms, 
menstrual problems, such as excessive bleeding, were most prevalent, followed 
by psychosomatic, sexual, and vasomotor symptoms. However, the 
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psychosomatic symptoms, such as lack of energy, forgetfulness, irritability, 
were the most distressful, compared to menstrual, sexual, and vasomotor 
symptoms. Vasomotor symptoms were the least frequently experienced and 
least distressful symptoms among four group of symptoms. This seems 
contradictory to contemporary health care view that women often seek help for 
vasomotor symptoms. It is possible that somen women with vasomotor 
symptoms may have been excluded from this study due to treatment with 
hormone replacement. 
The findings from this study suggest that physical activity is beneficial 
to psychosomatic symptoms. Although the effect is not dose dependent, both 
relatively active and active group had fewer psychosomatic symptoms than 
inactive. No relationships were found between vasomotor symptoms and the 
amount of physical activity, thus these findings do not support the use of 
physical activity as an alternative to hormone replacement therapy for 
vasomotor symptoms. This is of practical and consistent with public health 
value for perimenopausal women, for whom the issue of moderate physical 
activity is of greater interest. Long-term physical activity was also beneficial 
to psychosomatic symptoms. 
All perimenopausal symptoms except occurrence of vasomotor 
symptoms were significantly correlated with quality of life. The frequency of 
psychosomatic symptoms was the single significant symptom category 
predicting quality of life in perimenopausal women. 
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One third of this group of perimenopausal women was inactive, which 
suggests that more efforts are needed to change this sedentary population into 
an active one. African American and other ethnic minority women were less 
active than white Americans, and women who were widowed, separated, or 
divorced tended to have less long-term vigorous physical activity, and working 
women reported physical activity. Special efforts will be required to target 
these populations in which physical inactivity is particularly prevalent. 
The present results provide systematic evidence of a relationship 
between physical activity and some perimenopausal symptoms. This study 
therefore increases basic knowledge of perimenopausal symptoms and physical 
activity by identifying the relationships between the two factors. This 
conclusion is likely to be welcome news, especially for those women who wish 
to reduce some perimenopausal symptoms using nonpharmacological methods. 
It can also increase the confidence of those women who want to change from 
a sedentary to an active life style, in efforts to reduce risk of bone loss and 
cardiovascular disease. 
Unique educational opportunities exist when women can be informed of 
practical methods to reduce psychosomatic symptoms which were the most 
prevalent and most distressful to women in this study. With the information 
gained here, nursing interventions to promote physical activity can be tailored 
to reduce some perimenopausal symptoms. Information from this study can 
also lend an awareness of, and appreciation for, the relationship between 
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perimenopausal symptoms and physical activity. 
However, conclusions must be qualified in recognition of the study's 
limitations. Only 214 perimenopausal were investigated. In addition, some 
candidates in the available pool were excluded for the reasons given in 
Methods, thus further limiting generalizations. The differences between the 
respondents and non-respondents may have influenced our results, as the 
respondents had a higher level of education, which probably influenced their 
levels of physical activity. Lack of participation in recreational physical activity 
was more common in less well educated women. An improved techniques of 
data collection are needed to obtain higher responds rate. 
Future Research Recommendations 
This study was designed to examine the frequency and distress 
associated with symptoms experienced by perimenopausal women, and their 
relationship to physical activity using a cross-sectional design. Four groups of 
symptoms were experienced by perimenopausal women. Further research is 
needed to identify the relationship between these symptoms and menopausal 
status over time, from pre- to postmenopausal periods. A longitudinal design 
will help gain an understanding of how these symptoms behave over time. This 
would also provide opportunity to examine hormonal changes. 
Associations between the amount of physical activity and two 
dimensions of psychosomatic and sexual symptoms in perimenopausal women 
were also noted, however there was no compelling evidence to support a 
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conclusion that physical activity was causally related to enhanced 
psychosomatic and sexual health in these women. A well-controlled, 
longitudinal study is needed to clarity the causal relationships between physical 
activity and perimenopausal symptoms. 
Further study should investigate whether the relationships between 
physical activity and perimenopausal symptoms is also true in postmenopausal 
women. There is also a need to further clarify the relationships between 
physical activity and vasomotor symptoms. Women who participate in exercise 
programs may be used to study these relationships, offering a clearer 
understanding of the importance/nonimportance of physical activity and its 
influence on vasomotor symptoms during the transition into menopause. 
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Author/ Title I Sample 
Longcope, Franz, n=88; aged 
Morello, Baker, 45-58 yrs 
& Johnston, 
( 1986). Steroid 
and 
gonadotropin 
levels in women 
during the peri-
menopausal 
years. 
Trevoux, Brux, n=483; 
Castanier, Longitudinal 
Nahoul, Soule, & study over a 
Scholler (1986). period of 13 
Endometrium years 
and plasma 
hormone profile 
in the peri-
menopause and 
postmenopause 
APPENDIX A. 
HORMONAL ASPECT OF PERIMENOPAUSE 
Variables/ 
Instruments 
blood samples 
were obtained 
every 1-2 month 
and analyzed for 
estrogens, 
androgens and 
gonadotropin 
using 
radioimmunoassay 
techniques 
Endometrial 
histology and 
plasma levels of 
Follicle Stimulating 
Hormone (FSH), 
Lutealizing 
Hormone (LH), 
Estradiol (E2), 
Estrone (E 1) and 
Progesterone (P). 
Findings 
There is a gradual decline in ovarian estrogen secretion 
during the perimenopause. In most women, this gradual 
decline is not associated with episodes of vaginal bleeding, 
despite levels of estrogens which are capable of 
endometrial stimulation. There is a significant inverse 
correlation between estrogen and FSH concentrations. 
From Year-6 to year-3, gonadotrophin levels increased 
gradually while those of E2 remained normal, with peaks in 
some cases. Mean plasma P levels were within the normal 
range until year-3, but they then decreased progressively. 
From Year-3 to year+ 1 there was a concomitant rise in 
gonadotrophin as the E2 and P levels decreased. However, 
at the start of definitive amenorrhea, the mean E2 and P 
levels fluctuated between 60 and 100 pg/ml and between 
2 and 3 ng/ml, respectively. The endometrium was 
proliferative rather than atrophic. From year+ 1 to year+ 7, 
gonadotrophin reached a plateau at high levels while those 
of E2 continued to fall, reaching very low values at 
year+ 4, after which they reached a plateau. P levels were 
at the detection limit of the technique. 
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Richardson, 
Senikas, & 
Nelson, (1987). 
Follicular 
depletion during 
the menopausal 
transition: 
evidence for 
accelerated loss 
and ultimate 
exhaustion. 
Shideler, 
DeVane, Kalra, 
Benirchke, & 
Lasley, (1989). 
Ovarian-pituitary 
hormone 
interactions 
during the 
perimenopause 
n=17 
women aged 
45-55 yrs. 
(pre= 6, 
peri = 7, 
post= 4). 
n=5; 
women aged 
42-47 yrs 
(pre =3; 
peri = 2). 
APPENDIX A (cont.) 
Follicle numbers in 
one ovary from 
each woman. 
1 . Daily urine and 
random blood 
samples collected 
for 3 or 4 
consecutive 
cycles. 2. Estrone 
measured by urine. 
3. LH, FSH, P, E1, 
E2 measured using 
serum samples. 
The mean number of primordial follicles in the ovaries of 
premenopausal women was 10-fold higher than that in 
perimenopausal women. Follicles were absent in 
postmenopausal women. It was concluded that declining 
follicular reserve was the immediate cause of 
perimenopause. 
There are some forms of menstrual variability at the time of 
the perimenopause associated with lowered early follicular 
phase estrogen levels. Reduced negative feedback and 
subsequently increased gonadotrophin levels may have 
stimulated estrogen production which may have 
suppressed gonadotrophin secretion and lowered estrogen 
excretion. 
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Hee, 
MacNaughton, 
Bangah, & 
Burger, (1993). 
Perimenopausal 
patterns of 
gonadotrophin, 
immunoreactive 
inhibin, 
oestradiol and 
Progesterone 
n=10 
(pre= 7 aged 
34-44; 
peri =3 aged 
45-46). 
APPENDIX A (cont.) 
Radioimmunoassay Perimenopausal women have lower levels of E2 and P than 
of serum FSH, LH, premenopausal women but higher levels of E2 and P than 
E2, P. postmenopausal women. 
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Author/year Sample 
Magursky, 6877 women 
Mesko, & aged 38-58 yrs. 
Sokolik, 1975 
APPENDIX B. 
AGE AND THE DURATION OF PERIMENOPAUSE 
Design Variables/ Findings 
instruments 
Cross- Age of The mean age at the 
sectional menopause, age menopause was 51 yrs. 
survey and duration of The mean age at the onset 
perimenopause of the perimenopause was 
and factors 47.6 yrs. Women with 
influence onset menstrual disturbances had 
and duration of their menopause about 1 yr 
perimenopause earlier. Age at menarche 
measured by self- and parity had no effect on 
constructed the age at the onset of 
questionnaire that perimenopause. Women 
consisted of 25 working in agriculture and 
questions. house-wives had their 
menopause a little later 
than mean age of the 
sample, whereas manual 
workers and those in other 
occupational categories 
had their menopause and 
onset of the 
perimenopause about 1 
year earlier. 
Comments 
Retrospective 
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APPENDIX B (cont.) 
Treloar, 1981 n=291 women All women Menstrual history 
were measured by self-
followed constructed 
from the questionnaire. 
time of 
menarche to 
menopause. 
McKinlay, N = 1178 Longitudinal Menopausal 
Brambilla, & premenopausal study. status, 
Posner, 1992 women, aged Women demographics, 
45-55 yrs. were and a list of 22 
followed for signs/symptoms 
5 yrs by 
telephone 
interviews 
with 9-
month 
intervals. 
The age for the onset of 
perimenopause was 45.5 
years, with a range of 34 
to 55 yrs. The duration of 
perimenopause was 4.8 yrs 
with a range of 1 to 1 0 
years. The cyclic variability 
may be indicative of 
duration of the 
perimenopause. 
The median age at 
inception of perimenopause 
is 47.5 yrs and the 
duration is about four 
years. Smokers tend to 
have an earlier and a 
shorter perimenopause. 
Only the vasomotor 
symptoms are related to 
menopausal status. 
No 
psychometric 
parameters 
reported on 
tools used. 
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Author /year Menopausal 
status 
Jaszmann et pre 
al. (1969) peri 
post 
McKinlay et pre 
al. (1992) peri 
post 
Hunter pre 
(1992) peri & post 
Matthew et pre 
al. (1992) peri & post 
Kaufert et al. pre 
(1992) peri 
post 
Avis et al. pre 
(1993) peri 
post 
APPENDIX C. 
PREVALENCE OF SYMPTOMS DURING PERIMENOPAUSE (%) 
Vasomotor Depression Fatigue Irritability Sleep 
disturbance 
17 46 20 
40 55 35 40 
35 <50 15 30 
10 
50 
20 
24 13 27 
45 21 40 
6 19 7 
43 9 14 
26 
26 
26 
14 29 
37 38 
33 34 
Sexual 
disturbance 
27 
40 
Mood change 
I-' 
I-' 
I-' 
Koster & pre 31 12 
Davidsen peri 46 21 
(1993) post 68 16 
Dennerstein pre 10 25 
et al. ( 1993) peri 31 33 
post 39 29 
Shaver & pre 
Paulsen peri 
(1994) post 
Note: Empty box = Observations not made or reported. 
APPENDIX C (cont.) 
21 
30 
26 
38 32 
46 41 
38 40 
24 
35 
41 
43 
53 
64 
33 
34 
32 
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Author/year 
McKinlay et 
at., 1992 
APPENDIX D. 
THE RELATIONSHIP BETWEEN MENOPAUSAL STATUS AND SYMPTOMS REPORTED DURING MIDLIFE 
Sample Design Variables/ Findings Comments 
instruments 
N = 1178 women, Longitudinal study. Menopausal status, The median age at No 
aged 45-55 yrs. Women were demographics, and inception of psychometric 
followed for 5 yrs. a list of 22 perimenopause is 4 7. 5 parameters 
by telephone signs/symptoms yrs and the duration is reported on tool 
interview with 9- about four years. measuring 
month intervals. Smokers tend to have symptoms used. 
an earlier and a shorter 
perimenopause. Only 
the vasomotor 
symptoms are related 
to menopausal status. 
The relationship 
between 
perimenopause and 
symptoms reporting 
seems to be transitory, 
with reported rates 
showing an increase in 
the perimenopause and 
a compensatory 
decrease in the 
postmenopause. 
Women with longer 
perimenopause have 
more symptoms. 
1--' 
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APPENDIX D (cont.) 
Matthew et n = 541 initially 1 . Longitudinal 1 . Menopausal 
al., 1990 premenopausal design. 2. All status. 2. Physical 
women aged 42- women were and psychological 
50 yrs. After 3 followed for 3 yrs. symptoms 
years of follow- 3. Premenopausal experienced during 
up, pre= 101 and women ( n = 1 01 ) the previous 2 
post=69. were evaluated at weeks measured by 
baseline and 3 yrs a standard checklist 
later; of 27 symptoms 
postmenopausal (Neugarten 
women were &Kraines, 1964); 
evaluated at psychosocial 
baseline and within factors measured 
three months after by inventory 
their diagnosis of containing 
postmenopause. standardized 
personality tests of 
psychological 
factors. 
Kaufert et al., n = 4 77 initially Longitudinal design. 1 . Menopausal 
1988 premenopausal All women were status. 2. 
women aged 45- interviewed 6 times Symptoms 
55 yrs over a 3-yr period. measured by a 
checklist of 
physical, 
menopausal , and 
psychological 
symptoms. 
Vasomotor symptoms 
were significantly 
correlated with 
menopausal status. 
There were few 
changes in 
psychological 
characteristics. 
There was a significant 
relationship between 
vasomotor symptoms 
and menopausal 
status; there was no 
significant relationship 
between psychological 
symptoms and 
menopausal status. 
Sample size was 
relatively small 
compared with 
the complex 
analyses (Total 
of nine scales 
were used to 
measure the 
psychosocial 
status). 
No 
psychometric 
data reported on 
the tool 
measuring 
symptoms. 
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APPENDIX D (cont.) 
Hunter, 1 990 n=36 Prospective and 1 . Menopausal 
premenopausal longitudinal design. status 
women aged 45 Women were 2. Women's Health 
to 55 yrs interviewed at Questionnaire 
baseline and 3 (WHO) (total of 28 
years later items) 
Jaszmann et n = 2906 women Cross-sectional 1 . Menopausal 
al. 1969 (pre=999; survey (postal status. 2. 
peri =804; questionnaire) Symptoms 
post= 1103) measured by Blatt 
Menopausal Index. 
Holte & n = 2349 women cross-sectional 1 . Menopausal 
Mikkelsen, aged 45-55 yrs survey (postal status. 2. Symptom 
1991 were surveyed. questionnaire) checklist composed 
n = 1686 women of 24 items 
(pre=765, 
peri =88, 
post= 833) used 
in analysis. 
Vasomotor symptoms 
and depressed mood 
were significantly 
correlated with 
menopausal status; 
other psychological 
and sexual symptoms 
were not. 
All kinds of symptoms 
were more prevalent in 
peri- and 
postmenopausal 
women. 
Premenopausal women 
have significantly less 
vasomotor symptoms. 
Vasomotor complaints 
and vaginal dryness 
were the only variables 
significantly related to 
menopausal 
development. 
Small sample 
size. 
Premature 
menopausal 
women were 
included in their 
sample which 
limited the 
generalization of 
the study 
results. 
The reliability 
and validity of 
the tools used 
were not 
reported. 
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APPENDIX D (cont.) 
VanHall et n = 8679 women Cross-sectional 1 . Menopausal 
al., 1994 and men aged 25- design. Personal status. 
74. health interview. 2. Questions related 
(women= 4426, Subjects were to a variety of 
men=4253). divided into 6 complaints 
groups according to experienced during 
their ages rather the past two 
than menopausal weeks. 3. 
status. Psychosomatic 
symptoms 
measured by 
General Health 
Questionnaires 
(GHQ) and 
Biographic Problem 
List (BIOPRO) were 
also delivered. 
Except for excessive 
perspiration, none of 
the other complaints 
usually attributed to 
menopause increased 
more in women than in 
men during the 
perimenopausal period. 
It was concluded that 
psychosomatic 
complaints usually 
attributed to the 
climacteric are neither 
gender nor age specific 
and that, therefore, a 
hormonal cause for 
these complaints 
seems unlikely. 
Standardized 
three stage 
definitions were 
not utilized. 
Women were 
divided into 
groups 
according to 
their age instead 
of menopausal 
status 
I-' 
I-' 
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APPENDIX D (cont.) 
Koster & n=597 women Cross-sectional and 1 . Menopausal 
Davidsen, aged 51 years. retrospective for status. 2. 
1993. (pre=47, past 4 years. symptoms related 
peri =91, Postal questionnaire to menopause. 3. 
post= 129, significant life 
hormone events 
group= 125, 
surgical 
menopause= 84) 
Prevalence of hot 
flashes, moodiness and 
fatigue were 
significantly associated 
with menopause 
status. However, 
fatigue, moodiness and 
depression were more 
strongly associated 
with socioeconomic 
variables than 
menopause status. 
Sexual desire was not 
correlated with 
menopausal status. 
1 . Bias due to 
retrospectivity 
for four years. 
2. Relatively 
small sample of 
natural 
menopausal 
women. 3. 
Questionnaires 
were 
constructed by 
the researchers. 
The reliability 
and validity of 
tools were 
unknown. 
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APPENDIX D (cont.) 
Shaver & n = 135 women Cross-sectional 1 . Menopausal 
Paulsen, aged 37-59 yrs. design. Sleep status 2. Self-
1993 (pre and good quality and reported sleep 
sleep (GS)= 30, psychological stress quality using a 4-
pre and poor were compared in point scale in a 
sleep( PS)= 23, two groups of daily health diary. 
peri and GS= 20, menopausal women 3. Objective sleep 
peri and PS= 23, (divided by the pattern measured 
post and GS= 14, presence of the by the time to fall 
post and PS= 25). sleep disturbance) asleep from lights 
out to each stage of 
sleep and percent of 
time spent in each 
sleep stage and 
three summary 
indexes. 4. 
Psychological stress 
was measured by 
Symptoms 
Checklist 90 
(Derogatis, 1977) 
More than one-third of 
the midlife women 
reported poor sleep 
quality. But 
menopausal status and 
perceived sleep quality 
were not statistically 
related. Women with 
poor sleep reported 
higher levels of 
psychological distress 
and somatic symptoms 
than women reporting 
good sleep. 
....... 
....... 
'° 
APPENDIX D (cont.) 
Avis et al., Three groups of Cross-sectional 1 . Menopausal 
1993 women from survey using mailed status. 2. 
different cultures questionnaire Symptoms 
were studied. measured by a 
Samples included questionnaire 
8050 U.S. (adapted from 
women aged 45- Kaufert & Syrotuik, 
55 yrs, 1326 1 981 ) consisted of 
Canadian women 16 symptoms. 3. 
aged 40-59 yrs, Medication use 
and 1316 measured by self-
Japanese women constructed 
aged 45-55 yrs questions 
1. Women in the US 
are likely to begin 
experiencing 
menopause at an 
earlier age than 
Japanese or Canadian 
women. This may be 
due to the effect of 
smoking on age of 
menopause. 2. 
Japanese women, 
compared with 
Northern American 
women, report 
generally lower rates of 
a wide range of 
symptoms and 
commensurately low 
rates of medication 
use. 3. For the 
symptoms and 
medications 
considered, there is no 
or only a weak 
association between 
reported use and 
menopause status in 
Japanese women. 4. 
The association 
between menopause 
status and symptom or 
medication reporting 
was quite variable. 
Confounding 
variables (such 
as lifestyle and 
genetic factors) 
may influence 
the 
comparability of 
the study result. 
...... 
N 
0 
Hunter et al., n=682 women Cross-sectional 
1986. aged 45-65 survey using postal 
(pre= 124, questionnaire. 
peri = 177, and 
post=380). 
APPENDIX D (cont.) 
1 . Menopausal 
status. 2. 
Symptoms 
measured by 
Women's Health 
Questionnaire. 3. 
Social factors and 
general health 
measured by 
Pilowsky 
Hypochondriasis 
Questionnaire 
(1967) 
Vasomotor symptoms, 
depressed mood, and 
sexual difficulties were 
best predicted solely 
by menopausal status 
while other 
psychosomatic 
symptoms were more 
clearly associated with 
psychosocial factors. 
I-' 
N 
I-' 
APPENDIX E. 
THE RELATIONSHIP BETWEEN PHYSICAL ACTIVITY AND SYMPTOMS 
REPORTING IN MIDLIFE 
122 
Author /year 
Wilbur et al., 
1992 
I 
APPENDIX E. 
THE RELATIONSHIP BETWEEN PHYSICAL ACTIVITY AND SYMPTOMS REPORTING IN MIDLIFE 
Sample Design Variables/ Findings Comments 
instruments 
n=279 women The original study 1 . Menopausal Perimenopausal 
aged 37 to 64 was a longitudinal. status. 2. A 12- women had the 
yrs This report only month energy highest scores on 
concerned the expenditure symptoms than pre, 
results from a measured by self- post, and surgical 
cross-sectional report menopausal women. 
data. questionnaire. 3. Premenopausal group 
Symptoms had the lowest scores 
measured by the for vasomotor 
21-item Kaufert and symptoms. There was 
Syrotuik Symptoms a significant positive 
Index. relationship between 
occupational energy 
expenditure and 
vasomotor symptoms 
and general health. 
However, there was a 
negative correlation 
between leisure time 
energy expenditure 
and overall symptoms 
reporting. 
...... 
N 
w 
APPENDIX E (cont.) 
Wallace et n= 11 women, Longitudinal design 1 . Menopausal Both pre- and 
al., 1982 mean age of status. 2. Estrone postmenopausal 
pre= 43 yrs, and (E1), Estradiol (E2) women significantly 
mean age of & androgens increased level of E2. 
post=53.7 yrs measured by The E 1 and E2 profile 
radioimmunoassay. in postmenopausal 
women changed to 
premenopausal level. 
Severity of flashing 
changed in 55% of 
postmenopausal 
women. Exercise 
therapy appears to 
change symptoms 
during postmenopausal 
period 
Sample size was 
too small for 
adequate 
analyses. It was 
not clear how 
many women 
were 
premenopausal 
and how many 
were 
postmenopausal. 
In addition, it is 
not clear what 
kind of exercise 
program was 
applied to midlife 
women. 
Perimenopausal 
women as a 
group were not 
studied. 
,_. 
N 
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APPENDIX F. 
QUESTIONNAIRE BOOKLET 
ID 
Date 
A Study of Women's Health 
Suling Li, MSN, RN 
PhD Candidate 
Loyola University Chicago 
Office at the Loyola University Medical Center 
2160 First Ave 
Building 105, RM 2840 
Maywood, Il 60153 
Tel (708) 216-9577 
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DEMOGRAPHIC QUESTIONNAIRE 
I. What is your social security number 
2. What is your current age? __ (yrs) 
3. What is your race (Please circle only one) 
4. 
Caucasian .................. . 
Black . . . . . . . . . . . . . . . . . . . . . 2 
Hispanic . . . . . . . . . . . . . . . . . . . 3 
Asian ..................... 4 
American Indian/Alaskan Native . . . 5 
Pacific Islander . . . . . . . . . . . . . . . 6 
Other (specify) . . . . . . . . . . . . . . . 7 
What is your height? feet 
---
inches 
5. How much do you weigh __ (lbs) 
6. How many years of school have you completed so far? 
Less than 7th grade . . . . . . 1 
7 thru 9th grade . . . . . . . . . 2 
Partial high school 
(! 0-11 th grade) . . . . . . . . . 3 
High school grad . . . . . . . . 4 
Partial college . . . . . . . . . . 5 
College grad . . . . . . . . . . . 6 
Grad/Prof training . . . . . . . 7 
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7. Are you currently working at a job for pay? 
No ....... 0 
Yes . . . . . . 1 
7a: If yes, do you work full time or part time? 
Full time 
Part time ............. 2 
7b: If you are working, what is your occupation 
8. What is your current marital status? (Please circle only one) 
Never married . . . . . . . . . . 1 
Married . . . . . . . . . . . . . . 2 
Married but separated . . . . . 3 
Divorced ............. 4 
Widowed ............. 5 
Other (Please specify) 
~~~~~~~~ 
9. Which socio-economic level do you feel you belong to at the present time? 
Lower . . . . . . . . . . . . . . . 1 
Middle ............... 2 
Upper. . . . . . . . . . . . . . . . 3 
I 0. What was your household income, before ta"{es last year? 
less than $5,000 . . . . . . . . . 1 
$5.000to$19,999 ....... 2 
$20,000 to $39,999 . . . . . . 3 
$40,000 to $59,999 . . . . . . 4 
$60,000 to $79,999 . . . . . . 5 
$80,000 to $99,999 . . . . . . 6 
$100,000ormore ....... 7 
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WOMEN'S HEALTH ASSESSMENT 
This questionnaire is about the body changes and symptoms occurring during midlife 
and associated with perimenopause/menopause. This questionnaire asks what 
perimenopausal/menopausal symptoms you are currently experiencing or have 
experienced during the past year and how bothersome they are to you. 
NOTE: THIS QUESTIONNAIRE IS NOT ABOUT SYMPTOMS !<ELATED TO ANY CHRONIC CONDITIONS 
YOU MAY HAVE (For example, chronic backaches, chronic asthma). 
DIRECTIONS: The left column lists a variety of symptoms. Please read each symptom 
carefully and rate the frequency of the symptom in the middle column (Part A), 
0 never had, 
1 rarely, 
2 sometimes, 
3 often, 
4 always 
and then how bothersome in the right column (Part B), 
0 not at all, 
1 a little, 
2 moderately, 
3 quite a bit, 
4 extremely. 
Complete both columns before going on to the next symptom. If you never experience 
the symptom, you only need to complete Part A. 
EXAMPLE: Ms. Smith (47 years old) has experienced DIZZY SPELLS sometimes which are 
quite bothersome and COLD SWEATS rarely which are not bothersome at all, but she 
has never experienced HOT FLASHES during the past year. 
Symptom Part A Part B 
Have you experienced If you have experienced 
this symptom during this symptom during 
PERIMENOPAUSE (around PERIMENOPAUSE, how 
menopause)? bothersome was it? 
0 = never had, 0 = not at all, 
1 = rarely, 1 = a little, 
2 = sometimes, 2 = moderately, 
3 = often, 3 = quite a bit, 
4 = always 4 = extremely. 
1. hot flashes 0 1 2 3 4 0 1 2 3 4 
2. cold sweats 0 1 2 3 4 0 1 2 3 4 
3. dizzy spells 0 1 2 3 4 0 1 2 3 4 
APPENDIX F (cont.) 130 
-----------------------------.... -------------------------.... ---------------------------
Symptom 
! I 
1 Part A 1 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
I 
Have you experienced 
chis symptom during 
PERIMENOPAUSE (around 
l 
2 
3 
4 
menopause)? 
never had, 
rarely, 
sometimes, 
often, 
always 
Part B 
If you have experienced 
this symptom during 
PERIMENOPAUSE, how 
bothersome was it? 
0 not at all, 
l a little, 
2 moderately, 
3 quite a bit, 
4 extremely. 
------------------------------+--------------------------+---------------------------
1. hot 
flashes/flushes 
! I 
I 0 1 234 I 
I I 
I I 
I I 
0 1 2 3 4 
------------------------------+--------------------------+---------------------------
2. cold sweats O 1 2 3 4 : O 1 2 3 4 
I I 
------------------------------+--------------------------+---------------------------
3. dizzy spells O 1 2 3 4 : O 1 2 3 4 
I I 
------------------------------+--------------------------+---------------------------
4. lack of energy : O 1 2 3 4 O 1 2 3 4 
I I 
------------------------------+--------------------------+---------------------------
5. - diarrhea or 0 1 2 3 4 I I 
constipation 
1 
: 
0 l 2 3 4 
------------------------------+--------------------------+---------------------------
6. irritability o 1 2 3 4 : o l 2 3 
I I 
4 
------------------------------+--------------------------+---------------------------
?. persistent cough 0 1 2 3 4 : O l 2 3 4 
I I 
------------------------------+--------------------------+---------------------------! 8. restlessness 1 0 1 2 3 4 O 1 2 3 4 
I I 
------------------------------+--------------------------+---------------------------! 9. backaches 1 0 1 2 3 4 0 1 2 3 4 
I I 
------------------------------+--------------------------+---------------------------! 
10. nervous tension 1 O l 2 3 4 O 1 2 3 4 
I I 
------------------------------+--------------------------+---------------------------
11. aches and 
stiffness in 
I 
I 
I 
I 
0 1 2 3 4 
joints : 1 
0 1 2 3 4 
------------------------------+--------------------------+---------------------------
' 12. upset stomach : 0 l 2 3 4 
1 
O 1 2 3 4 
------------------------------+--------------------------+---------------------------
' I 13. headaches 1 O 1 2 3 4 1 
I I 
0 1 2 3 4 
------------------------------+--------------------------+---------------------------
' I rapid heart beat : O l 2 3 4 : O 1 2 3 14. 4 
------------------------------+--------------------------+---------------------------
15. shortness of 
breath 
' I IQ 1 234 I 0 
I I 
I I 
I I 
1 2 3 4 
------------------------------+--------------------------+---------------------------
16. ' I ea~ly.morning : O 1 2 3 4 : 0 1 2 3 4 
waKening : : 
_____________________________ ..J.. _________________________ ..J.. ___________________________ _ 
APPENDIX F (cont.) 131 
-----------------------------..,--------------------------..,----------------------------
Symptom Part A 
Have you experienced 
this symptom during 
PERIMENOPAUSE (around 
menopause)? 
0 never had, 
l 
2 
3 
4 
r-arely, 
sometimes, 
often, 
always 
Part B 
If you have experienced 
this symptom during 
?ERIMENOPAUSE, how 
bothersome was it? 
o not at all, 
2 
3 
4 
a. l.:.ttle 1 
moderately, 
quite a bit, 
extremely. 
------------------------------+--------------------------+---------------------------
17. sore throat or 
cold 
0 1 2 3 4 I I 
I 
I I 
0 1 2 3 4 
------------------------------+--------------------------+---------------------------
18. "pins and needles" 
in hands or feet 
0 1 2 3 4 I I 
I 
I I 
0 1 2 3 4 
------------------------------+--------------------------+---------------------------
19. leaking of urine 
when laughing or 
0 1 2 3 4 
I 
I 
I 
I 
coughing 
1 
: 
0 1 2 3 4 
------------------------------+--------------------------+---------------------------
20. loss of appetite O 1 2 3 4 : O 1 2 3 
• I I 
4 
------------------------------+-----------~--------------+---------------------------
21. fluid retention O 1 2 3 4 I 0 1 2 3 4 
I I 
------------------------------+--------------------------+---------------------------
' 0 1 2 3 4 I 
I I 
22. forgetfulness 0 2 4 1 3 
------------------------------+--------------------------+---------------------------
23. difficulty 
concentrating 
0 1 2 3 4 I I 
I 
I I 
0 1 2 3 4 
------------------------------+--------------------------+---------------------------
24. bladder infection I 0 1 2 3 4 : O 1 2 3 4 
I I 
------------------------------+--------------------------+---------------------------
' I loss of interest 1 O 1 2 3 4 1 
in things : : 
I I 
25. 0 1 2 3 4 
------------------------------+--------------------------+---------------------------
26. lack of enjoyment o 1 2 3 4 : O 1 2 3 4 
I I 
------------------------------+--------------------------+---------------------------
27. miserable and sad : o 1 2 3 4 : o 1 2 3 4 
I I 
------------------------------+--------------------------+---------------------------! I 28. decreased feelings 1 O 1 2 3 4 1 O 1 2 3 4 
of well-being : : 
I I 
------------------------------+--------------------------+---------------------------
' I 29. life not worth 1 O 1 2 3 4 1 O l 2 3 4 
living : : 
I I 
------------------------------+--------------------------+---------------------------
' I 3 o. frightened 1 O 1 2 3 4 1 O 1 2 3 4 
/panicky feelings : : 
I I 
-----------------------------....1...-------------------------....1...---------------------------
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Symptom ' I 1 Part A 1 
: Have you experienced : 
: this symptom during I 
: PERIMENOPAUSE (around : 
: 
0 
menopause)? / 
1 never had, 1 
/ 1 rarely, I 
: 2 sometimes, : 
: 3 often, : 
: 4 always : 
Part B 
If you have experienced 
this symptom during 
PERIMENOPAUSE, how 
bothersome was it? 
0 not at all, 
l a little, 
2 moderately, 
3 quite a bit, 
4 extremely. 
------------------------------+--------------------------+---------------------------
31. anxiety leaving 
house alone 
0 l 2 3 4 I I 
I 
I I 
0 1 2 3 4 
------------------------------+--------------------------+---------------------------
32. difficulty falling : 0 1 2 3 4 : 0 1 2 3 4 
asleep : : 
------------------------------+--------------------------+---------------------------
33. breast tenderness O 1 2 3 4 : 0 l 2 3 4 
I I 
------------------------------+--------------------------+---------------------------
34. bloated stomach : 0 l 234 0 1 2 3 4 
I I 
------------------------------+--------------------------+---------------------------
0 1 234: 0 l 2 3 
I I 
4 35. abdominal cramps 
------------------------------+--------------------------+---------------------------
36. feeling 
unattractive 
' I IQ 1 234 I 
I I 
I I 
I I 
0 l 2 3 4 
------------------------------+--------------------------+---------------------------
37. clumsiness : O 1 2 3 4 0 1 2 3 4 
I I 
------------------------------+--------------------------+---------------------------
38. not lively or 
excited 
0 1 2 3 4 I I 
I 
I I 
0 1 2 3 4 
------------------------------+--------------------------+---------------------------
39. scanty or 
infrequent 
menstrual flow 
0 1 2 3 4 I I 
I 
I 
I 
I I 
0 l 2 3 4 
------------------------------+--------------------------+---------------------------
40. irregular 
menstrual flow 
' I IQ l 234 I 
I I 
0 
I I 
I I 
1 2 3 4 
------------------------------+--------------------------+---------------------------
41. deficient amount 
of menstrual flow 
but periods are 
regular 
0 l 2 3 4 
I 
I 
I 
I 
I 
I 
I 
I I 
0 1 2 3 4 
------------------------------+-------------~------------+---------------------------
42. excessive bleeding O l 2 3 4 I O l 2 3 4 
ac the time of a : 
menstrual period, : 
either in number : 
of days or amount 1 
of blood or both : 
I I 
-----------------------------...l..-----~-------------------...l..---------------------------
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Symptom 1 I 1 Part A 1 
: Have you experienced 1 
1 this symptom during 
PERIMENOPAUSE (around 
0 
1 
2 
3 
4 
menopause)? 
never had, 
rarely, 
sometimes, 
often, 
always 
Part B 
If you have experienced 
this symptom during 
PERIMENOPAUSE, how 
bothersome was it? 
0 not at all, 
1 a little, 
2 moderately, 
3 quite a bit, 
4 extremely. 
------------------------------+--------------------------+---------------------------! 43. bleeding from the O 1 2 3 4 : O 1 2 3 4 
uterus at any time 1 
other than during : 
the.menstrual : 
pen.od 
1 
I 
------------------------------+--------------------------+---------------------------
44. vaginal dryness 0 1 2 3 4 : O 1 2 3 4 
I I 
------------------------------+--------·-------------------+---------------------------
45. decrease in sexual 
desire/interest 
0 1 2 3 4 I I 
I 
I I 
0 1 2 3 4 
------------------------------+--------------------------+---------------------------
46. painful 
intercourse (if 
you are not 
sexually active, 
please skip this 
row) 
! I 
I 0 l 234 I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
0 1 2 3 4 
------------------------------+--------------------------+---------------------------
47. dissatisfaction 
with sexual 
relationship (if 
you are not 
sexually active, 
please skip this 
row) 
! I 
IQ 1 234 I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
I I 
0 1 2 3 4 
------------------------------+--------------------------+---------------------------
48. other (specify) : 0 1 2 3 4 ! I 
I 
I 
I 
I 
I 
I 
I 
I I 
0 1 2 3 4 
------------------------------+--------------------------+----------------------------
49. other (specify): 0 1 2 3 4 ! I 
I 
I 
I 
I 
I 
I 
I 
I 
0 1 2 3 4 
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QUALITY OF LIFE DURING PERIMENOPAUSE 
Perimenopause is defined as experiencing irregular periods or no period for 3 to 
11 months. 
' ... How do you rate your overall quality of life BEFORE EXPERIENCING 
PERIMENOPAUSE? Please circle a number from 1 to 10, with 1 meaning that 
your quality of life has been very poor and 10 meaning that your quality of 
life has been very good. 
1 2 
very poor 
quality of life 
3 4 5 6 7 8 9 10 
very good 
quality of life 
2. How do you rate your overall quality of life right now? Please circle a 
number from 1 to 10, with 1 meaning that your quality of life has been very 
poor and 10 meaning that your quality of life has been very good. 
1 2 
very poor 
quality of life 
3 4 5 6 7 8 9 10 
very good 
quality of life 
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LONG-TERM PHYSICAL ACTIVITY QUESTIONNAIRE 
DIRECTIONS: Please circle the number or mark the appropriate box to answer each 
question. In some instances it will be necessary to fill in blanks with further 
information. 
P1. DURING THE PAST YEAR, HOW OFTEN DID YOU PARTICIPATE IN VIGOROUS 
PHYSICAL ACTIVITIES such as, dance, basketball, gymnastics, running, 
aerobics, or field hockey, briskly walking uphill or with a load, fast or racing 
cycling ( > 10 mph), fast treading or crawl swimming, stair ergometer, ski 
machine conditioning exercise, single tennis, racketball, fishing in stream, 
rapidly canoeing ( > 4 mph), moving furniture, mowing lawn (hand mower)? 
(PLEASE CIRCLE ONLY ONE CHOICE WHICH BEST DESCRIBES YOUR 
ACTIVITY STYLE) 
daily .................... 1 
4-6 times per week . . . . . . . . . 2 
2-3 times per week ......... 3 
one time per week . . . . . . . . . . 4 
1-3 times per month . . . . . . . . 5 
never ................... 6 
If you practice any VIGOROUS activity, ON AVERAGE, state how many minutes do 
you do VIGOROUS activity on a single time? (_) 
P2. If you have practiced the VIGOROUS physical act1v1ty style you described 
above for more than one year, then specifically state how many years? 
( ) YEARS 
Please describe your VIGOROUS activities: 
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P3. DURING THE PAST YEAR, HOW OFTEN DID YOU PARTICIPATE IN MODERATE 
PHYSICAL ACTIVITIES such as briskly walking (3-4 mph); Cycling for pleasure 
or transportation ( < 10 mph), moderate effort swimming, general calisthenics, 
table tennis, golf (pulling cart or carrying clubs), fishing (standing/casting), 
leisurely canoeing (2.0-3.9 mph), painting (home repair), mowing lawn (power 
mower), volleyball, softball, or working at a job that involved active cleaning 
such as scrubbing floors and vacuuming? (PLEASE CIRCLE ONLY ONE CHOICE 
WHICH BEST DESCRIBES YOUR ACTIVITY STYLE) 
daily .................... 1 
4-6 times per week ......... 2 
2-3 times per week ......... 3 
one time per week . . . . . . . . . . 4 
1-3 times per month . . . . . . . . 5 
never ................... 6 
If you practice any MODERATE activity, ON AVERAGE, state how many minutes do 
you do MODERATE activity on a single time? (_) 
P4. If you have practiced the MOD ERA TE physical actrvrty style you described 
above for more than one year, then specifically state how many years? 
( ) YEARS 
Please describe your MOD ERA TE activities: 
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CURRENT PHYSICAL ACTIVITY QUESTIONNAIRE 
DIRECTIONS: Please circle the number or mark the appropriate box to answer each 
question. In some instances it will be necessary to fill in blanks with further 
information. 
P1. DURING A TYPICAL WEEK IN THE LAST MONTH, HOW OFTEN DID YOU 
PARTICIPATE IN VIGOROUS PHYSICAL ACTIVITIES such as, dance, basketball, 
gymnastics, running, aerobics, or field hockey, briskly walking uphill or with a 
load, fast or racing cycling ( > 10 mph), fast treading or crawl swimming, stair 
ergometer, ski machine conditioning exercise, single tennis, racketball, fishing 
in stream, rapidly canoeing ( > 4 mph), moving furniture, mowing lawn (hand 
mower)? (PLEASE CIRCLE ONLY ONE CHOICE WHICH BEST DESCRIBES 
YOUR CURRENT ACTIVITY STYLE) 
daily .................... 1 
4-6 times per week . . . . . . . . . 2 
2-3 times per week . . . . . . . . . 3 
one time per week . . . . . . . . . . 4 
1 -3 times per month . . . . . . . . 5 
never ................... 6 
If you practice any VIGOROUS activity, ON AVERAGE, state how many minutes do 
you do VIGOROUS activity on a single time? (_) 
Please describe your VIGOROUS activities: 
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P2. DURING A TYPICAL WEEK IN THE LAST MONTH, HOW OFTEN DID YOU 
PARTICIPATE IN MODERATE PHYSICAL ACTIVITIES such as briskly walking 
(3-4 mph); Cycling for pleasure or transportation ( < 10 mph), moderate effort 
swimming, general calisthenics, table tennis, golf (pulling cart or carrying 
clubs), fishing (standing/casting), leisurely canoeing (2.0-3.9 mph), painting 
(home repair), mowing lawn (power mower), volleyball, softball, or working at 
a job that involved active cleaning such as scrubbing floors and vacuuming? 
(PLEASE CIRCLE ONLY ONE CHOICE WHICH BEST DESCRIBES YOUR 
CURRENT ACTIVITY STYLE) 
daily .................... 1 
4-6 times per week . . . . . . . . . 2 
2-3 times per week ......... 3 
one time per week . . . . . . . . . . 4 
1 -3 times per month . . . . . . . . 5 
never ................... 6 
If you practice any MODERATE activity, ON AVERAGE, state how many minutes do 
you do MODERATE activity on a single time?(_) 
Please describe your MODERATE activities: 
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AMERICAN HEART ASSOCIATION PHYSICAL ACTIVITY QUESTIONNAIRE 
1995 
Choose the column (A, B or C) that best describes your usual level of physical 
activity. Rate your activity level: 
Column A ......... 1 
Between Column A and B?. 
Column B .......... 3 
Between Column B and a+ 
Column C . . . . . 5 
A B 
HIGHLY ACTIVE MODERATELY 
ACTIVE 
My job requires very My job requires that 
hard physical labor (such I walk, list, carry or 
as digging or loading do other moderately 
heavy objects) at least hard work for 
four hours a day several hours per 
OR day (day care 
I do vigorous activities worker, stock clerk 
(jogging, cycling, or busboy/waitress) 
swimming, etc.) at least OR 
three times per week for I spend much of my 
30-60 minutes or more leisure time doing 
OR moderate activities 
I do at least one hour of (dancing, gardening, 
moderate activity such walking or 
as brisk walking at least housework) 
four days a week 
c 
INACTIVE 
My job requires that I 
sit at a desk most of 
the day 
AND 
much of my leisure 
time is spent in 
sedentary activities 
(watching TV, 
reading, etc.) 
AND 
I seldom work up a 
sweat and I cannot 
walk fast without 
having to stop to 
catch my breath 
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HEALTH HISTORY 
The following questions are about your menstrual history: 
1. How old were you when you had your first menstrual period? 
__ (Age) 
2. At what age, did your menstrual periods become regular, that is, you could usually predict about 
when they would start? 
___ (Age) 
___ Never became regular 
3. Did your periods become regular naturally, or because of taking birth control pills, or in some 
other way? 
Naturally ............... . 
Birth control pill . . . . . . . . . . 2 
Some other way . . . . . . . . . . . 3 
4. Please check the one response that best describes your menstrual cycles over the past 12 months: 
!). I menstruated over the past 12 months, and my periods were regular, for me 
2). I was pregnant or breastfeeding during the past 12 months, and my periods were 
infrequent or absent 
3). I menstruated over the past 12 months, but my periods were irregular, or infrequent, or 
different, for me 
4). I did not menstruate over the past 3-11 months. 
5). I did not menstruate over the past 12 months because I have gone through a natural, or 
non-surgical menopause and therefore I no longer menstruate. 
6). I did not menstruate over the past 12 months because I have had my uterus and/or both 
ovaries removed, therefore. I no longer menstruate 
5. In general, are or were, you able to predict. within a few days, when your next period would 
begin? That is. were your menstrual periods regular'1 
I don't know; I never paid attention to my period .............................. 8 
No. they were not generally regular . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ....... 0 
Y <!S, they were generally regular . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...... . 
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5a. If yes, how often. on the average, did or do your menstrual periods come? 
Every days 
6. Was there any time in your life when there were more than 40 days between the beginning of one 
period and the beginning of the next, or when your periods stopped for at least six months (not 
including when you were pregnant or breastfeeding)? 
No .............. 0 
Yes ............ . 
7. Have you ever had premenstrual syndrome? 
No .................... 0 
Yes ................. · · 
Don't know .............. 2 
8. Circle any of the members of your family listed below who ever suffered from perimenopausal 
symptoms and describe their symptoms if you can? 
No one ................. 0 
Your mother . . . . . . . . . . . . . 
Your sister . . . . . . . . . . . . . . 2 
Your mother's mother ....... 3 
Your father's mother . . . . . . . . 4 
Your mother's sisters . . . . . . . 5 
Your father's sisters . . . . . . . . 6 
Please describe 
9. Have you ever been pregnant? 
No 
yes 
............ 0 
a. If yes, circle the number that represents the outcomes of each pregnancy and include the 
number of times each occurred: 
I =live birth # 
2=induced abortion # ___ _ 
3=miscarriage or spontaneous abortion # ____ _ 
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4=stillbirth # 
5=ectopic tubal pregnancy # 
6=other (specify) ______________ _ # 
-----
I 0. Have you ever taken oral contraceptives, or birth control pills for reasons other than regulating 
your period? 
No .......................... 0 
Yes ....................... , . 
The following questions are about your medical history: 
11. Have you ever been told by a nurse or a doctor that you had any of the following conditions? 
Circle each one you have had or currently have. 
I) Drinking problem or alcoholism 
2) Angina/Chest pain 
3) Heart Attack 
4) High blood pressure/hypertension 
5) Stroke 
6) Tuberculosis 
7) Chronic bronchitis or emphysema 
8) Allergy 
9) Stomach ulcers 
10) Chronic colitis/Crohn · s disease 
11) Diabetes 
12) Kidney or renal disease 
13) Bladder problems 
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14) Liver disease/hepatitis 
15) Arthritis 
16) Osteoporosis 
17) Polycystic ovaries 
18) Anorexia Nervosa 
19) Infertility 
20) Endometriosis 
21) Abnormal pap smear 
22) Cancer 
23) Thyroid disease 
24) Other-specify 
The following questions are about any medications you are taking now: 
12. Have you taken any of the following pills within the past year? 
a. Beta Carotene Yes No 
b. Vitamin A Yes No 
c. Vitamin B Yes No 
d. Vitamin C Yes No 
e. Vitamin E Yes No 
f. Iron Yes No 
a Multivitamins Yes No ~ 
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If you have taken any of the following within the past year, please list the name, the dose and the 
frequency of each medication below and the date that you last took the medication. 
13. Please list any prescribed medications you regularly take: 
14. Please list any over the counter medications you routinely take: 
15. Please list any medications you have ever taken to relieve perimenopausal symptoms (For example, 
Rejuvex): 
The last question is about your smoking history: 
16. Which one of the following best describes you: 
Never smoked ...................................................... 0 
Never smoked but live with a smoker . . . . . . . . . . . ............ . 
Have smoked for six month or longer but quit ................ 2 
Currently smoke ..................................................... 3 
If you have ever smoked or are currently smoking, how many years have you smoked 
_______ (yrs), and how many packages doidid you smoke a day ______ (pack/day). 
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You did it ! 
Congratulations! 
We appreciate all the time and thought you put into 
answering these questions. 
Please check that you didn't leave any questions 
blank 
Return this booklet in the attached self-addressed 
stamped envelope as soon as possible 
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IRB APPROVAL 
LOYOLA UNIVERSITY INSTITUTIONAL REVIEW SOARD FOR THE PROTECTION OF 
HUMAN SUBJECTS-MEDICAL CENTER 
Li, Suling LU NUMBER: 7424.00 
The influence of regular physical activity on perimenopause. 
Dear Investigator: 
Attached is the full approval for your research project. 
The date of full approval is 12/11/95. 
This approval expires on 12/10/96 which is the date of the first scheduled 
periodic review of a research activity. 
The frequency of review of this research project will be l2 months. 
You are approved to enroll 88 participants in your research project. 
IF YOU WISH TO EXCEED THIS NUMBER YOU MUST PROVIDE WRITTEN JUSTIFICATION AND 
SEEK THE PRIOR APPROVAL OF THE BOARD. 
Please note that the Loyola Institutional Review Board for the Protection of 
Human Subjects is appropriately constituted and has been granted Multiple 
Projects Assurance Number M-1387 (effective 05/01/94 to 04}30/99). 
Attached are an amendment report form, an adverse protocol reaction form, 
a temporary protocol closure notice, request to resume protocol activity 
after temporary closure and a permanent closure form. These forms are to be 
used when reporting actions to the IRB. The blank forms may be xeroxed 
and used for subsequent amendments, adverse protocol reactions and 
temporary closure notification for THIS PROJECT ONLY. 
Thank you. 
147 
148 
APPENDIX G (cont.) 
,YOLA UNIVERSITY INSTITUTIONAL REVIEW BOARD FOR THE PROTECTION OF HUMAN 
HUMAN SUBJECTS (MEDICAL CENTER) 
PROTOCOL AMENDMENTS/REVISIONS 
REQUIRING IRB ACTION 
NOTIFICATION OF FULL APPROVAL OF AMENDMENT 
LU NUMBER: 7424.00 INVESTIGATOR: Li , Suling 
AMEND 1 : See PI letter dated 12/13/95. 
Further considerations now suggest that 500 women will be needed 
to achieve statistical significance. 
1. DATE OF REVIEW: 12/20/95 
2. SUBSTANTIVE (SUBS) OR ADMINISTRATIVE (ADMIN) CHANGE: ADMIN 
J. EXPEDITED (ER) OR FULL BOARD (FB) REVIEW: FB 
4. EFFECT OF AMENDMENT ON RISK TO THE PATIENT 
(INCrease, DECrease, NoChange): NC 
5. CHANGES NECESSARY TO THE INFORMED CONSENT DOCUMENT (Y/N): N 
(12/20/95- 7424112095] 
6. WILL THE BOARD REQUIRE THAT PAST OR CURRENT PARTICIPANTS BE APPRISED 
OF THE NEW INFORMATION (Y/N) : N 
COMMENTS: None. 
ACTION (APProve, Conditional Approval, Table, DISapprove): APP 
IF PREVIOUSLY TABLED: 
DATE OF REREVIEW: ACTION OF REREVIEW: 
DATE OF APPROVAL: 12/20/95 
KENNETH CRAIG MicETICH, M.D. 
CHAIRMAN, INSTITUTIONAL REVIEW BOA.al) (MEDICAL CENTER) 
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Date 
Subject's Name 
Street Address 
City, State Zip code 
Dear Ms. 
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APPENDIX H. 
COVER LETTER 
In 1992, you participated in the Women Take Heart Study at St. James Medical 
Center, Chicago Heights. I am presently a doctoral student at Loyola University 
Medical Center and am now working with Dr. Al-Hani, the principal 
investigator, and Dr. Holm, a member of the medical advisory committee for 
Women Take Heart, to extend the study by examining the relationships 
between physical activity and health during perimenopause/menopause. 
Perimenopause, the period before and after menopause, is a time when women 
experience changes in their menstruation pattern, for example, having a longer 
or shorter interval between periods or excessive or scanty bleeding, or no 
period for three to eleven months. Many women find the symptoms associated 
with these changes to be bothersome or distressing. We believe it is important 
to study what can be done to relieve or prevent distressful symptoms. 
Therefore, we would like to invite you to participate. If you agree, please 
complete the enclosed questionnaires which should take approximately 25 
minutes. 
This research project is also part of the requirement for my Ph.D. degree in the 
Graduate School of Nursing, Loyola University of Chicago. Dr. Al-Hani and Dr. 
Holm are on my research committee. 
Your participation is voluntary. All responses and identifying information will 
be kept strictly confidential. Your completion and return of the questionnaires 
will be an indication of your consent and willingness to participate in this study. 
Some of the participants will be asked to complete the questionnaires again at 
a later date. 
The completed questionnaire can be faxed to me at (708) 327-9183, or you 
can mail it to me at Loyola University Medical Center, 2160 South First 
Avenue, Maywood, Illinois, 60153. 
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If you have any questions, I can be reached at (708) 216-9577 on most week 
days between 9AM to 5PM, Chicago time or leave a message on my voice mail 
(708) 327-9173. Dr. Holm, the supervising nurse scientist for this project can 
be reached at (708) 216-3831 at the Department of Medical-Surgical Nursing 
at Loyola University Medical Center. 
If you have any questions concerning your rights as a research participant, 
please contact Kenneth C. Micetich, M.D., Chairman, Institutional Review 
Board for the Protection of Human Subjects, Loyola University Medical Center, 
708-21 6-4608. 
We sincerely appreciate your participation in this study. The information we 
learn will help us to provide better care to our midlife women who are going 
through perimenopause/menopause. 
Thank you for your time 
Sincerely, 
Suling Li RN MSN 
Ph.D candidate 
cc: Dr. Al-Hani 
Dr. Holm 
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Subject's Name 
Street Address 
City, State Zip code 
Dear Ms. 
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RETEST COVER LETTER 
Thank you for completing the questionnaire for the Women's Health study. As 
directed by my research committee (Dr. Al-Hani and Dr. Holm), it is necessary 
to have you complete the same questionnaire again to assess consistency of 
women's responses. 
Please complete the enclosed questionnaire and return it to me in the 
addressed, stamped envelope within two weeks. Again, your participation is 
voluntary. If you have any questions, please do not hesitate to call. I can be 
reached at (708) 216-9101 on most week days between 9AM to 5PM, Chicago 
time or leave a message on my voice mail (708) 327-9173. Dr. Holm, the 
supervising nurse scientist for this project can be reached at (708) 216-3831 
at the Department of Medical-Surgical Nursing at Loyola University Medical 
Center. 
Thank you for your time 
Sincerely 
Suling Li RN MSN 
Ph.D candidate 
cc: Dr. Al-Hani 
Dr. Holm 
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Subject's Name 
Street Address 
City, State Zip code 
Dear Ms. 
155 
APPENDIX J 
PILOT COVER LETTER 
When women reach a certain age, they go through a time when they experience changes in 
their menstruation pattern, for example, having a longer or shorter interval between periods or 
excessive or scanty bleeding. Many women find the symptoms associated with these changes 
to be bothersome or distressing. I believe it is important to study what can be done to relieve 
or prevent distressful symptoms. Therefore, if you are: experiencing changes in your menstrual 
pattern; aged 40 and above; not on hormone replacement therapy or oral contraceptives within 
the past five years; and have no history of hysterectomy or bilateral oophorectomy, I invite you 
to participate in a study of how regular physical activity affects this time of transition. Taking 
part in the study involves filling out a questionnaire booklet which takes about 20 minutes. The 
booklet includes a Women's Health Assessment Scale, Physical Activity Questionnaire, a Health 
History and a Demographic Questionnaire. 
You will find the booklet enclosed with this letter. If you agree to participate in this study, 
please answer all of the questions to the best of your ability. Your name is not needed 
anywhere on the booklet, so your answers will be confidential. If you have any questions, 
please call me at (708) 327-9173 or (708) 216-9101. 
I would appreciate it if you could return the questionnaire booklet within two weeks after 
receiving it. The completed booklet can be mailed to me at Loyola University Chicago, Medical 
Center, School of Nursing, Building 105, Room 2840. 
I sincerely appreciate your participation in this study. The information I learn will help us to 
provide better care to our midlife women who are going through perimenopause/menopause. 
Sincerely 
Suling Li, RN, MSN 
PhD Candidate 
School of Nursing 
Bldg 105 - RM 2840 
LUMC 
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